Tony

WASHINGTON — A Virginia-based sailor is the fourth sailor to die in February from the coronavirus, the Navy announced Tuesday. The sailor was assigned to Assault Craft Unit 4 based at Joint Expeditionary Base Little Creek in Virginia Beach, according to a statement by Expeditionary Strike Group 2. The individual had tested positive for the coronavirus Friday and was admitted to Sentara Leigh Hospital in Norfolk on Saturday.

WASHINGTON — Millions of people enrolled in Tricare Prime can now receive the coronavirus vaccine from an outside provider without incurring fees, according to the Defense Health Agency. The waiver allows enrollees — excluding active-duty service members — to receive the vaccine at a non-network Tricare provider without incurring additional service fees. Typically, a person with Prime would have to receive a referral from their doctor to receive services from another clinic. The waiver will apply to about 3.3 million Tricare Prime enrollees, according to the Military Health System website.

UNCLASSIFIED// ROUTINE R 232232Z FEB 21 MID200000605754U FM CNO WASHINGTON DC TO NAVADMIN INFO CNO WASHINGTON DC BT UNCLAS NAVADMIN 046/21 MSGID/NAVADMIN/CNO WASHINGTON DC/CNO/FEB// SUBJ/CHIEF OF NAVAL OPERATIONS PROFESSIONAL READING PROGRAM (CNO-PRP) REVISIONS (CORRECTED COPY)// RMKS/1. Nearly 200 years ago, the Navy ordered its ships be outfitted with a reading list of 37 books in order to help train and educate Sailors. The leaders of the Navy knew then what is still the case today: to out think our competitors we must study and apply lessons we have learned from our past. Furthermore, it is critically important for our Navy to be a learning organization. One of the very best ways to do that is to foster an environment where every Sailor deepens their level of understanding and learning. 2. That is why we are launching an updated Chief of Naval Operations Professional Reading Program (CNO-PRP) reading list, with a motto of Read Well to Lead Well. The updated list can be found at the CNO Reading Program website: https://www.navy.mil/CNO-Professional-Reading-Program. 3. This year we significantly revised the CNO-PRP to better serve Sailors, who will help our fighting force expand their personal and professional development beyond that of their primary designators and ratings. More than just a reading list, actively participating in the CNO-PRP will: - Enhance professionalism and improve critical thinking skills - Foster a deep appreciation for Naval and military history and heritage - Increase knowledge of joint warfighting and strengthen the ability to make sound decisions - Develop greater appreciation of the views of others and a better understanding of our changing world - Encourage discussion about the maritime profession and the evolving role of modern Seapower 4. The structure of the program was revised to make books more accessible to Sailors. Specific changes include: - Alignment of 53 titles with my four key lines of effort: Sailors, Readiness, Capabilities, and Capacity. They are sub-divided into tiers of Foundational, Advanced, and Capstone, indicating which books are appropriate during various stages of a Sailors career - 21 books MCPON has identified as recommended reading 5. Most of the 74 CNO-PRP titles will be available in both e-book and digital audio format from the Navy MWR digital library overdrive collection at: https ://www.Navymwrdigitallibrary.org. Security restrictions may limit the ability to download these books on Navy-owned computers, so downloading them to personally -owned devices is encouraged. 6. This list is not intended to discourage additional professional reading in any way. Rather, it serves to provide easy access to just a few of the many titles that will benefit our Sailors and ultimately our service. The entire list, with book summaries and additional information, is available at https://www.navy.mil/CNO-Professional-Reading-Program. 7. Actions: Commanders, Commanding Officers, and Officers in Charge will: a. Actively promote the CNO-PRP, incorporating it into command professional education programs and general military training by creating opportunities to read and discuss the books. b. Develop innovative methods to promote active participation in the CNO- PRP. In the past, many commands established reading groups, essay contests, and special liberty rewards for dedicated professional readers. 8. Warfighting development is essential to our force, especially in great power competition. Reading, discussing, and understanding the ideas found in these books will not only improve ourselves, but also improve our knowledge contributing to maintaining our warfighting advantage. I encourage everyone serving to use reading as another way to prepare and continue to develop themselves in our great Navy and to hold fast to our core values of Honor, Courage, and Commitment. Remember, Read Well to Lead Well. 9. Released by Admiral Mike Gilday, Chief of Naval Operations. BT #0001 NNNN UNCLASSIFIED//

NORFOLK, Virginia — If an aircraft carrier did not have Aviation Boatswain's Mates (Equipment), also known as ABEs, carriers would just be carrying aircraft. Flight operations wouldn't be possible, and one of the carrier's primary missions couldn't be accomplished. ABEs assigned to USS Gerald R. Ford (CVN 78), work with first-in-class technology known as Advanced Arresting Gear (AAG) and Electromagnetic Aircraft Launch System (EMALS). Ford's ABEs are specifically charged with learning these new systems and paving the way for future Ford-class carriers.

Families of three slain U.S. service members and 13 others wounded in a mass shooting at Naval Air Station Pensacola in 2019 alleged Monday that the government of Saudi Arabia facilitated the attack that U.S. authorities concluded was an act of international terrorism. A 152-page complaint in federal court in Pensacola makes startling new allegations that the shooter, Royal Saudi Air Force 2nd Lt. Ahmed Mohammed al-Shamrani, executed the attack with the support of "accomplices." Those included fellow Saudi air force trainees, who he told of his plans at a dinner the night before and during a November visit to the 9/11 memorial in New York City to pay tribute to the hijackers, the plaintiffs alleged.

YOKOSUKA NAVAL BASE, Japan – An investigation is underway at the home of the 7th Fleet after the child of a Navy civilian employee was found unresponsive Thursday in the family’s off-base home, a spokesman for the installation said. The child was pronounced dead after being taken to Yokosuka Kyosai Hospital, not far from the naval base, spokesman Randall Baucom told Stars and Stripes in an email Friday evening.

If you are having technical issues with PMK-EE: ✔ If using Navy eLearning, email nel_helpdesk.fct@navy.mil or ✔ Login to NeL and select the HELP button in the lower right corner or ✔ If using the mobile app, email Sfly_pmkee_questions@navy.mil

Feb 2021 Sailor to Sailor Newsletter

Some families at military bases caught in this week’s freezing temperatures are faced with moving from base housing due to broken water pipes and no utilities, while others are banding together to support one another during the crisis. At least eight bases remained closed Thursday in states including Texas, Oklahoma and Louisiana, with many preparing to stay closed Friday. Most will spend an entire week with only essential personnel on base as extremely cold weather has created dangerous conditions across southern portions of the country. The region is not accustomed to multiple days of below freezing weather, snow or substantial ice accumulation, which has led to unnavigable roads, broken water pipes and overwhelmed utilities.

The Navy this year will be firing a high-energy laser weapon that is fully integrated with one of its destroyers, which proponents say is a major step toward fielding directed energy technology. Joe Ottaviano, Lockheed Martin business development director for advanced product solutions, said he has heard the adage that battlefield lasers always seem to be “one year away” from fielding, but asserted that this time is different.

UNCLASSIFIED// ROUTINE R 172230Z FEB 21 MID600050280963U FM CNO WASHINGTON DC//N1// TO NAVADMIN INFO CNO WASHINGTON DC//N1// BT UNCLAS NAVADMIN 042/21 PASS TO OFFICE CODES: FM CNO WASHINGTON DC//N1// INFO CNO WASHINGTON DC//N1// MSGID/GENADMIN/CNO WASHINGTON DC/N1/NOV// SUBJ/RESCINDING IMPLEMENTATION OF EXECUTIVE ORDER ON COMBATING RACE AND SEX STEREOTYPING// REF/A/MSG/CNO WASHINGTON DC/061441ZNOV20// REF/B/EXECUTIVE ORDER 13985/PRESIDENT/20JAN21// REF/C/MEMO/SECDEF/29JAN21// REF/D/MSG/SECNAV WASHINGTON DC/162345ZFEB21// NARR/REF A IS NAVADMIN 300/20 IMPLEMENTATION OF EXECUTIVE ORDER 13950 ON COMBATING RACE AND SEX STEREOTYPING. REF B IS EXECUTIVE ORDER 13985 ON ADVANCING RACIAL EQUITY AND SUPPORT FOR UNDERSERVED COMMUNITIES THROUGH THE FEDERAL GOVERNMENT. REF C IS SECDEF MEMO RESCINDING IMPLEMENTATION OF EXECUTIVE ORDER ON COMBATING RACE AND SEX STEREOTYPING MEMORANDUM REF D IS ALNAV 011/21 CANCELLATION OF ALNAV 095/20// RMKS/1. This NAVADMIN cancels and replaces reference (a) and provides updated policy guidance on inclusion and diversity training per references (b) through (d). 2. Effective immediately, Navy will resume all Inclusion and Diversity (I&D) training. There is no requirement for commands to submit training for review by higher authority but OPNAV N17 welcomes the submission of commands I&D training syllabus or summaries to the Office of Inclusion and Diversity at ALTN_USN_INCLUSION_AND_DIVERSITY(at)navy.mil for archiving purposes. 3. For questions concerning updated Navy Inclusion and Diversity policy, contact the OPNAV N17 Office of Inclusion and Diversity at ALTN_USN_INCLUSION_AND_DIVERSITY(at)navy.mil. 4. This NAVADMIN will remain in effect until superseded or canceled, whichever occurs first. 5. Released by Vice Admiral John B. Nowell, Jr, N1.// BT #0001 NNNN UNCLASSIFIED//

UNCLASSIFIED// ROUTINE R 172121Z FEB 21 MID600050280827U FM CNO WASHINGTON DC TO NAVADMIN INFO CNO WASHINGTON DC BT UNCLAS NAVADMIN 041/21 PASS TO OFFICE CODES: FM CNO WASHINGTON DC//N1// INFO CNO WASHINGTON DC//N1// MSGID/GENADMIN/CNO WASHINGTON DC/N1/FEB// SUBJ/FY-22 COMMAND MASTER CHIEF SENIOR ENLISTED LEADER BOARD RESULTS// REF/A/DOC/CNO/20OCT20// NARR/REF A IS OPNAVINST 1306.2J, COMMAND SENIOR ENLISTED LEADER PROGRAM.// RMKS/1. Congratulations to the following Active Component (AC) members who have been selected for assignment as a Command Master Chief from the Command Senior Enlisted Leader Board, which convened 1 February 2021: NAME (LAST FIRST MI) RATE PARENT COMMAND ADAMS SHARON L OSCM COM2FLT BARNES JEFFREY R FTCM SSBN 733 GOLD CR BLOOM DAVID J SOCM NSW BRANAM RICHARD C II ITSCM SSBN 741 M BLUE BROWN DANIEL S III FTCM TTF KINGS BAY BRUNST MICHAEL J SOCM NSW BRYANT JOSE U EODCM NSWC IHEODTD EXU BULLARD ANDREW G SOCM NSW BUSH BRANDON R MMNCM DIRDIVOFNREACDOE CHO STEVE Y EODCM EODMU 8 CLIFTON BRENT F SOCM NSW COX TERUEDUM A FTCM COMSUBRON 21 CURTIN THOMAS F ITSCM SSGN 728 GOLD CR DAVIS PAUL F CTRCM CWG 6 DET DIGBY ERIKSON THOMAS A ETVCM NSSC PH EVENER JASON J SOCM NSW FLEMMING JEFFERY A EMCM CNAVSURFG MIDPAC FOWLES DANIEL A SOCM NSW FRANK ERIC MMACM SUBTRAFAC SD GLOWINKOWSKI PAUL A SOCM NSW GOULAS ADAM N HMCM SSN 790 S DAKOTA GRAY RYAN M SBCM NSW GRIFFIN SETH D SOCM NSW HAMMANN STACY R STSCM SSGN 729 BLUE CR HARR NICHOLAS H ETVCM COMUSWFORPAC HARTWELL JOSEPH B SBCM NSW HICKEY NATHAN P AWRCM CHSMWINGPAC HOLLINGSWORTH CARTER H ETCM NAVBASE VC PMUGU HOLZHAUSEN ZACHARY W EODCM EODMU 2 HOUSKE JEREMY S HTCM LHD 6 BONHOMME R JAMES JOSEPH D AOCM COMNAVAIRPAC JOSEPH NAKISHA M OSCM COMNAVSURFLANT KNOTT MICHAEL L MMNCM CNAL TRNG TEAM LAWYER CHRISTOPHER P SOCM NSW LAZARIN FRANCISCO HMCM NMRTC PORT LINCOLN GREGORY M SOCM NSW MARION CAROLINE Y MACM CVN 72 LINCOLN MARTIN ROGER L EODCM EODMU 6 MAY JAMES B MMACM SSGN 726 GOLD CR METZGER BRIAN S ENCM SWSC NEWPORT RI MITCHELL NATHANIEL J SOCM NSW MORALES JESSICA M ABCM MESG-1 MORALES JOSEPH A SOCM NSW PINE JOHN R MMACM SSBN 734 TN GOLD PLASENCIA ARTURO B ITSCM SSN 717 OLYMPIA RIVERA JONATHAN M QMCM CVN 75 H TRUMAN ROUTHIER SHAWN P SOCM NSW RUBIC ELIZA S HMCM NMRTC LEMOORE SARNOSKI DAVID SOCM NSW SHAFFER DANAL J ETVCM SSN 757 ALEX SIMONDS CHARLES A ETVCM SSN 789 INDIANA SKINNER LEE T MMACM SSBN 735 BLUE CR STANLEY BRIAN C EODCM EOD TRA/EVAL U 2 STEPHENSON GARY R ITSCM SSN 751 SAN JUAN SWANSON KEVIN S MMACM SSN 723 OKLA CTY TAYLOR ADAM D SOCM NSW TILDEN RUSSELL D AVCM LHD 4 BOXER TOTH DANIEL J SOCM NSW TRAVIS DAVID M EODCM EODMU 12 TREKSON JEREMY K SOCM NSW TSCHANNEN BRIAN D EODCM NDIVESALVTRACEN WAGOR MATTHEW C SOCM NSW WALLACE ANDREW C SOCM NSW WATTS JOSEPH A LSSCM SSN 782 MS WILLIAMSON BRADLEY M ENCM EWTGLANT NORVA WILTSHIRE COLLIN L ETVCM SLC GROTON CT YEBOA SIMEON K CSSCM ARDM 5 ARCO 2. Congratulations to the following Full-Time Support (FTS)/Selected Reserve (SELRES) members who have been selected for assignment as a Command Master Chief: NAME (LAST FIRST MI) RATE PARENT COMMAND FRANCIS JERMAIN M AFCM VR 62 HINDERBERGER MICHAEL EQCM NMCB 14 DET 2914 JOHNSON SCOTT A UCCM NMCB 25 DET 2925 MANGUM JOSHUA W ISCM NR NSW IWC 18 MCCARTY MICHAEL G CUCM NMPS DET NORFOLK MCGREGOR ROBERT W DCCM COMDESRON 31 RAMIREZ NITO V AVCM FRCR MW DET FTW 3. AC POC is CMDCM(SW/AW) William P. Houlihan, NAVPERSCOM PERS-40FF at 901-874-4560, DSN 882-4560, email william.houlihan(at)navy.mil. SELRES POC is YNCS Michelle Lang, COMNAVRESFOR at 757-322-2432, DSN 262-2432, email michelle.m.lang1(at)navy.mil. FTS POC is CMDCM(FMF/AW) Darryl E. Williams, NAVPERSCOM PERS-4012C at 901-874-3257, DSN 882- 3257, email darryl.e.williams(at)navy.mil. 4. Selectees should contact their respective POC soonest to discuss detailing opportunities. 5. Released by Vice Admiral John B. Nowell, Jr, N1.// BT #0001 NNNN UNCLASSIFIED//

UNCLASSIFIED// ROUTINE R 172107Z FEB 21 MID600050280775U FM CNO WASHINGTON DC TO NAVADMIN INFO CNO WASHINGTON DC BT UNCLAS NAVADMIN 040/21 PASS TO OFFICE CODES: FM CNO WASHINGTON DC//N1// INFO CNO WASHINGTON DC//N1// MSGID/GENADMIN/CNO WASHINGTON DC/N1/FEB// SUBJ/FY-22 COMMAND SENIOR CHIEF SENIOR ENLISTED LEADER BOARD RESULTS// REF/A/DOC/CNO/20OCT20// NARR/REF A IS OPNAVINST 1306.2J, COMMAND SENIOR ENLISTED LEADER PROGRAM.// RMKS/1. Congratulations to the following Active Component (AC) members who have been selected for assignment as a Command Senior Chief from the Command Senior Enlisted Leader Board, which convened 1 February 2021: NAME (LAST FIRST MI) RATE PARENT COMMAND ABEL MATTHEW T CSCS DDG 52 BARRY AVALLONE MICHAEL G MMCS MARMC NORVA BARCUS KISHA L BMCS JNT BASE PHH TPU BARMAN ADAM W ETCS TOC WHIDBEY IS BLANCO LAURA HMCS NMTSC ENL TR EL CARMAN CHRISTOPHER J AWOCS VP 5 CHARLES MILLARD G AOCS HSC-12 CHRISTOPHER CARL RSCS CVN 78 FORD CRUZDELOSSANTOS JOSELIN J LSCS NCTAMS PACW HI DORTRAIT ANDRE YNCS VFA 2 DUCKSWORTH GROVER MMCS ATG MAYPORT ENGLISH RICHARD III OSCS CSCS UNIT DNECK FELIX JESUS A ITSCS CNAVPERSCOM MILL FORD KIMBERLY A BMCS CSCS DET E NRFK GALARZA TODD J MACS SBASE K BAY SDET GARCIA JORGE A GSCS COMLCSRON ONE GWILT DANIEL W MNCS LCS CREW 112 HALL BENJAMIN A MNCS MIW DIV 22 HARDEMON JESSICA E OSCS DDG 87 MASON HASSLER STEVEN G MNCS LCS CREW 205 HAYLOW MATTHEW C MACS CFA OKI SE JIMENEZ MARCUS LSCS LCS CREW 212 JOHNSON KEITH K ABFCS LHA 6 AMERICA JOHNSON LEDEZMAN A RSCS LSD 46 TORTUGA JULIEN JOEZETTE D HMCS NMRTC NE D SARAT KESTNER SHAUN L HMCS USNMRTC ROTA KHORSHED MOHAMED K EMCS CNSS 5 LOZOYA JESUS A NCCS CG 65 CHOSIN LYNCH BRUCE A ADCS VFA 34 MAJORS BRANDON R HTCS LSD 50 CARTER H MARRERO GRISEL ITCS SOUTHCOM JIC MEJIA ANDRES R MACS MESG-1 TEU MILES SETH A ISCS CUS OPCONCEN MULLENBERG JASON R NCCS NSSC PH NELSON DEREK GEORGE NCCS TAOC DET LA NEW EDMOND C III ADCS LHD 6 BONHOMME R PARE EDWARD BENJAMIN MACS NRFK NS SEC DET PERRAS CHRISTOPHER M FCACS COMSEVENTHFLT PETERSON THOMAS W HMCS 1ST REGT 1ST DIV PICKLE PHILLIPP P BMCS NAVBASE VC PMUGU PORTER MIKENDRA R HMCS USNMRTC OKINAWA RAMIREZ VENA S YNCS COMUSFLTFORCOM REECE DOUGLAS M OSCS DDG 54 C WILBUR ROSS MATTHEW E BMCS CVN 76 RONALD REAGAN SLADE CARLOS T MACS NS MAYPORT SECDT SMITH JACKEY J MCCS CNR HAWAII STUBBS DENNIS M OSCS NRD JAX FLA SWINNEY CHRISTOPHER HMCS LPD 28 PCD NORVA TAYLOR MICHAEL J MNCS LCS CREW 116 TURNER DAWN MMCS NLEC DAM NECK VALLE MANUEL HMCS COMDESRON 15 VINES TERRY L BMCS CNRSW VOSBURG BRYON A AWRCS HSM-77 WOLFINGER IOANA L HMCS LSD 50 CARTER H 2. Congratulations to the following Full-Time Support (FTS)/Selected Reserve (SELRES) members who have been selected for assignment as a Command Senior Chief: NAME (LAST FIRST MI) RATE PARENT COMMAND GRASSE AMY J ASCS CMSW OCONNELL WILLIAM R SR HMCS 2ND NELR SIMPKINS WILLIAMS J AWFCS CNAFR DET MILLIN STIGALL CHARLES A DCCS NAVRTC SUP DET 3. AC POC is CMDCM(SW/AW) William P. Houlihan, NAVPERSCOM PERS-40FF at 901-874-4560, DSN 882-4560, email william.houlihan(at)navy.mil. SELRES POC is YNCS Michelle Lang, COMNAVRESFOR at 757-322-2432, DSN 262-2432, email michelle.m.lang1(at)navy.mil. FTS POC is CMDCM(FMF/AW) Darryl E. Williams, NAVPERSCOM PERS-4012C at 901-874-3257, DSN 882- 3257, email darryl.e.williams(at)navy.mil. 4. Selectees should contact their respective POC soonest to discuss detailing opportunities. 5. Released by Vice Admiral John B Nowell, Jr, N1.// BT #0001 NNNN UNCLASSIFIED//

UNCLASSIFIED// ROUTINE R 162345Z FEB 21 MID600050271607U FM SECNAV WASHINGTON DC TO ALNAV INFO SECNAV WASHINGTON DC CNO WASHINGTON DC CMC WASHINGTON DC BT UNCLAS ALNAV 011/21 MSGID/GENADMIN/SECNAV WASHINGTON DC/-/FEB// SUBJ/CANCELLATION OF ALNAV 095/20// REF/A/EXECUTIVE ORDER/PRESIDENT/20JAN21// REF/B/EXECUTIVE ORDER/PRESIDENT/22SEP20// REF/C/MEMO/SECDEF/29JAN21// REF/D/ALNAV/SECNAV/04NOV20// NARR/REF A IS EXECUTIVE ORDER (EO) 13985 ADVANCING RACIAL EQUITY AND SUPPORT FOR UNDERSERVED COMMUNITIES THROUGH THE FEDERAL GOVERNMENT. REF B IS EO 13950 COMBATING RACE AND SEX STEREOTYPING. REF C IS MEMO FROM SECRETARY OF THE DEFENSE RESCINDING IMPLEMENTATION OF EXECUTIVE ORDER ON COMBATING RACE AND SEX STEREOTYPING MEMORANDUM. REF D IS ALNAV 095/20/ IMPLEMENTATION OF EXECUTIVE ORDER ON COMBATING RACE AND SEX STEREOTYPING (HEREBY CANCELLED).// RMKS/1. The President of the United States issued guidance in reference (a) establishing policy that the Federal Government should pursue a comprehensive approach to advancing equity for all, including people of color and others who have been historically underserved, marginalized, and adversely a?ected by persistent poverty and inequality. Reference (a) revokes reference (b) and directs the head of each agency to review and identify proposed and existing agency actions related to or arising from EO 13950, and consider suspending, revising, or rescinding any such actions. In accordance with reference (a) and reference (c), reference (d) is hereby cancelled. 2. Effective immediately, all Department of the Navy civilian and military personnel training relating to diversity and inclusion is authorized to resume without any higher-level approval as previously required in reference (d). 3. In accordance with reference (c), the Chief of Naval Operations and the Commandant of the Marine Corps are required to review existing agency actions related to reference (b), and report on any actions identified for revision or retraction. 4. My primary points of contact in this matter are Ms. Kimberly Lane, (202) 685-6210, kimberly.lane@navy.mil for civilian personnel training, and Ms. Heather McIntosh-Braden, (703) 693-4489, heather.mcintosh1@navy.mil, for military training. 5. Released by the Honorable Thomas W. Harker, Acting Secretary of the Navy.// BT #0001 NNNN UNCLASSIFIED//

More than a dozen military bases stretching from Fort Drum in New York to Fort Hood in Texas were closed Tuesday as large swaths of the country were gripped by freezing temperatures and dangerous weather conditions. In southern portions of the United States, many residents were dealing with freezing temperatures and power and water outages.

The guided-missile destroyer USS Winston S. Churchill (DDG 81) seized illicit shipments of weapons and weapons components from two stateless dhows during a maritime security operation in international waters off the coast of Somalia, Feb. 11-12.

UNCLASSIFIED// ROUTINE R 160550Z FEB 21 MID600050259196U FM CNO WASHINGTON DC TO NAVADMIN INFO SECNAV WASHINGTON DC CNO WASHINGTON DC BT UNCLAS NAVADMIN 037/21 MSGID/NAVADMIN/CNO WASHINGTON DC/CNO/FEB// SUBJ/U.S. NAVY COVID-19 STANDARDIZED OPERATIONAL GUIDANCE VERSION 4.0// REF/A/NAVADMIN/OPNAV/042056ZNOV20// REF/B/NAVADMIN/OPNAV/171541ZAPR20// REF/C/NAVADMIN/OPNAV/021507ZJUL20// REF/D/MEMO/OSD/13APR2020// REF/E/MEMO/OSD/11JAN2021// REF/F/INST/OSD/24AUG2020// REF/G/MEMO/NMCPHC/24JUL2020// REF/H/GUIDE/BUMED/17JUL2020// REF/I/MEMO/NMCPHC/13APR2020// REF/J/MEMO/BUMED/07AUG2020// REF/K/NAVADMIN/OPNAV/241512ZAUG20// REF/L/NAVADMIN/OPNAV/212043ZOCT20// REF/M/NAVADMIN/OPNAV/082145ZJUL20// REF/N/GENADMIN/JCS/211347ZAUG20// REF/O/MEMO/OSD/05OCT2020// REF/P/INST/OPNAV/16DEC2019// REF/Q/MEMO/OSD/29DEC2020 REF/R/NAVADMIN/OPNAV/161751ZDEC20 // REF/S/NAVADMIN/OPNAV/072031ZJAN21 // REF/T/DOC/NMCPHC/19JAN2021// REF/U/DOC/NMCPHC/05FEB2021// NARR/REF A IS NAVADMIN 298/20, U.S. NAVY COVID-19 STANDARDIZED OPERATIONAL GUIDANCE VERSION 3.1. REF B IS NAVADMIN 113/20 RESTRICTION OF MOVEMENT (ROM) GUIDANCE UPDATE. REF C IS NAVADMIN 189/20, NAVY MITIGATION MEASURES IN RESPONSE TO CORONAVIRUS OUTBREAK UPDATE 6. REF D IS USD P&R FHP SUPPLEMENT 8 - DOD GUIDANCE FOR PROTECTING PERSONNEL IN WORKPLACES DURING THE RESPONSE TO THE COVID-19 PANDEMIC. REF E IS USD P&R FORCE HEALTH PROTECTION (FHP) SUPPLEMENT 15 - DOD GUIDANCE FOR COVID-19 CLINICAL LABORATORY DIAGNOSTIC TESTING SERVICES. REF F IS DODI 6490.03, DEPLOYMENT HEALTH, 19JUN19. REF G IS NAVY AND MARINE CORPS PUBLIC HEALTH CENTER MEMO EVALUATING CDC 20 JULY 2020 UPDATE ON RETURN TO WORK GUIDANCE AT CDC WEBSITE WWW.CDC.GOV/CORONAVIRUS/2019-NCOV/HCP/DURATION-ISOLATION.HTML. REF H IS CORONAVIRUS DISEASE READINESS GUIDE VERSION 1.1, 17JUL20. AT WEBSITE ESPORTAL.MED.NAVY.MIL/BUMED/RH/M3/M34/CRG/DEFAULT.ASPX. REF I IS NAVY AND MARINE CORPS PUBLIC HEALTH CENTER MEMO 2019 NOVEL CORONAVIRUS (COVID-19) CASE AND CONTACT INVESTIGATION GUIDE AT WEBSITE ESPORTAL.MED.NAVY.MIL/SITES/NMCPHC/PPS/WPPC19/COVID19_CONTACT _INVESTIGATION _CONTACT_TRACING_GUIDE.ASPX. REF J IS BUMED MEMO FLEET CONTACT TRACING RING APPROACH AT WEBSITE HTTPS://COMMUNITY.MAX.GOV/PAGES/VIEWPAGE.ACTIONPAGEID=2157064930&ATTACHMENTID =2159706846. REF K IS NAVADMIN 236/20, UPDATED PROCEDURES FOR FOREIGN VISIT REQUESTS TO U.S. NAVY COMMANDS DURING COVID-19 PANDEMIC. REF L IS NAVADMIN 283/20 NAVY MITIGATION MEASURES IN RESPONSE TO CORONAVIRUS OUTBREAK UPDATE 6 MODIFICATION 1. REF M IS NAVADMIN 194/20 FACE COVERINGS IN UNIFORM.// REF N IS GENADMIN COVID-19 TESTING INSTRUMENT REQUEST FOR INFORMATION AND ENDURING REPORTING REQUIREMENTS. REF O IS THE DEPUTY SECDEF MEMO FOR SENIOR PENTAGON LEADERSHIP REGARDING APPROVAL AUTHORITY FOR ORDERING BIOFIRE TEST PANELS FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2. REF P IS OPNAV INSTRUCTION 5726.8C, OUTREACH: AMERICAS NAVY DATED 16 DECEMBER 2019. REF Q IS USD P&R FORCE HEALTH PROTECTION (FHP) SUPPLEMENT 12 - DOD GUIDANCE FOR PERSONNEL TRAVELING DURING THE CORONAVIRUS DISEASE 2019 PANDEMIC. REF R IS NAVADMIN 327/20 SARS-COV-2 VACCINATION AND REPORTING POLICY. REF S IS NAVADMIN 03/21 DEPARTMENT OF DEFENSE COVID-19 TESTING PRIOR TO OVERSEAS TRAVEL. REF T IS NAVY AND MARINE CORPS PUBLIC HEALTH CENTER MODELING RESULTS FOR US NAVY FORCE HEALTH PROTECTION CONSIDERATIONS WITH INCREASING COVID-19 IMMUNIZATION RATES. REF U IS NAVY AND MARINE CORPS PUBLIC HEALTH CENTER SUPPLEMENTARY DATA FOR US NAVY FORCE HEALTH PROTECTION CONSIDERATIONS WITH INCREASING SARS-COV-2 IMMUNIZATION RATES: 85% CREW VACCINATION AND CREW SIZE 500. POC/RADM KARL THOMAS/OPNAV N3N5B/703-692-9291/KARL.O.THOMAS1(AT)NAVY.MIL// RMKS/1. [NEW] THIS MESSAGE UPDATES THE U.S. NAVY COVID-19 STANDARDIZED OPERATIONAL GUIDANCE VERSION 3.1 ISSUED IN REF (A). REF (A) IS CANCELLED. NOTABLE CHANGES IN THIS UPDATE ARE: (1) ADDS DEFINITIONS RELATED TO VACCINATION AND IMMUNIZATION IN PARA 2; (2) LAYS FOUNDATION FOR UNITS THAT HAVE HIGH PERCENTAGE OF IMMUNIZED MEMBERS (BEGINNING WITH 100% IMMUNIZED UNITS IN PARA 3.C.1 AND 4.A.4) AND ENABLES NCCS TO ADJUST ROM REQUIREMENTS FOR IMMUNIZED INDIVIDUALS IN PARAS 1.C.1, 3.B. AND 3.C.; (3) UPDATES QUARANTINE GUIDANCE IN PARA 2.G.2, 7.B AND 7.B.1 IN ACCORDANCE WITH CENTER FOR DISEASE CONTROL AND FORCE HEALTH PROTECTION GUIDANCE 15 (REF (E)); (4) ALLOWS FLEET SURGEONS TO CONSIDER DEPLOYING HIGH RISK INDIVIDUALS ON HIGHLY IMMUNIZED CREWS IN PARA 3.A.2; (5) ADJUSTS PARA 3.B.2 AND 4.E. TO PROVIDE NCC A RISK-INFORMED REDUCTION IN TRAVEL-ROM DURATION IAW FORCE HEALTH PROTECTION GUIDANCE 14 (REF (Q)); (6) ALLOWS NCCS TO REDUCE ROM REQUIREMENTS FOR IMMUNIZED SHIP RIDERS IN PARA 3.E.; (7) ADDS T-AH/CVN/LHD/LHA TO MEDICAL CONSIDERATION IN 2.P, 3.C.1 AND PARA 4.B.1; (8) PROVIDES GENERAL GUIDANCE ON IMMUNIZATION THROUGHOUT AND SPECIFICALLY IN PARA 12; (9) PROVIDES GUIDANCE FOR TIERED TESTING (NON-DIAGNOSTIC TESTING) REQUESTS AND REPORTING IN PARA 13, AND (10) PROVIDES GUIDANCE FOR COMMUNITY OUTREACH IN PARA 13. ADDITIONAL GRAMMATICAL AND ADMINISTRATIVE CORRECTIONS WITHIN THE SOG ARE MINOR AND DO NOT CHANGE THE INTENT OF ANY PARAGRAPH. TO ASSIST IN UNDERSTANDING CHANGES TO SOG 4.0, NEW PARAGRAPHS HAVE [NEW] AT THE BEGINNING AND PARAGRAPHS WITH CHANGES HAVE [MOD] AT THE BEGINNING. NCC, FLEET, TYCOM AND OPERATIONAL COMMANDERS MAY ISSUE ADDITIONAL GUIDANCE TO SUBORDINATE UNITS. COVID-19 VACCINES ARE RAPIDLY BEING DEPLOYED ACROSS THE FLEET IAW WITH DOD PRIORITY SCHEMES OUTLINED IN PARA 12.C. VACCINATION WILL SIGNIFICANTLY HELP PROTECT OUR SAILORS FROM THE RISK OF INFECTION, AND IN THE UNLIKELY CHANCE A SAILOR BECOMES INFECTED AFTER IMMUNIZATION (NO VACCINE IS 100% EFFECTIVE) SIGNIFICANTLY MINIMIZE THE SEVERITY OF THE ILLNESS. STUDIES ARE ONGOING TO UNDERSTAND IF RECEIVING THE VACCINE ELIMINATESTHE ABILITY TO TRANSMIT THE VIRUS, BUT UNTIL THERE IS MEDICAL VALIDATIONTO SUPPORT THIS PREMISE, MANY SHIPBOARD SITUATIONS WILL REQUIRE A CONTINUATION OF RIGOROUS HEALTH PROTECTION MEASURES AND BUBBLE GENERATION. THERE WILL SOON BE INSTANCES WHERE UNITS HAVE A HIGH PERCENTAGE OF IMMUNIZED SAILORS. THIS NAVADMIN WILL INTRODUCE OPPORTUNITIES TO REDUCE ROM REQUIREMENTS FOR IMMUNIZED INDIVIDUALS, ELIMINATE QUARANTINE FOR IMMUNIZED SAILORS WHO RECEIVED THEIR FINAL DOSE WITHIN THE PAST THREE MONTHS, EXPAND OPPORTUNITIES IN SAFE HAVEN PORTS FOR LIBERTY, REDUCE ROM FOR UNITS AND INDIVIDUALS IN TRAINING TRACKS PREPARING TO DEPLOY OR WHILE CONDUCTING PCS TO JOIN A UNIT. IN SHORT, FULLY IMMUNIZED SAILORS WILL ALLOW OUR NAVY TO BEGIN TO UNWIND THE LIMITATIONS THAT HAVE BEEN PLACED ON OUR SAILORS AT SEA WHERE THERE ARE LIMITED THREAT VECTORS BUT WHERE THE CONSEQUENCE OF PENETRATING A BUBBLE IS GREATEST. THE HIGHER THE PERCENTAGE OF THE CREW IMMUNIZED, THE LESS RISK THERE IS TO A WIDESPREAD OUTBREAK. HAVING KEY AND ESSENTIAL WATCHSTANDERS AND PERSONNEL IMMUNIZED PROVIDES MISSION ASSURANCE AND INCREASES DEPTH ON THE BENCH. RAPID AND THOROUGH FORCE IMMUNIZATION WILL ALLOW COMMANDERS GREATER LATITUDE TO MANAGE OPERATIONAL RISK. CREWS WHO ACHIEVE 100% IMMUNIZATION MAY IMMEDIATELY TAKE ADVANTAGE OF THIS BENEFIT BY ELIMINATING ROM-SEQUESTER, RELAXING HEALTH PROTECTION MEASURES IAW PARA 3.C.1 AND OPERATING AT SEA WITH GREATER CONFIDENCE AND CREW EFFICIENCY. AS WE LEARN MORE ABOUT THE VACCINES AND THE REDUCED RISK IT AFFORDS OUR SAILORS, THIS SOG WILL EVOLVE TO INCLUDE CREWS WITH LOWER UNIT IMMUNIZATION LEVELS. 1.A. TO INCREASE PROBABILITY OF A COVID-FREE MISSION READY CREW, UNITS WILL ADHERE TO THE FOLLOWING STANDARDIZED OPERATIONAL GUIDANCE. THESE DATA DRIVEN RISK MITIGATION MEASURES PROVIDE COMMANDERS THE TOOLS TO PREVENT AND WHEN NECESSARY CONTAIN COVID-19, TO REDUCE THE IMPACT TO OUR FORCE WHILE SAFELY AND CONFIDENTLY REMAINING ON MISSION. THIS GUIDANCE BUILDS ON REFS (B) AND (C) WHILE INCORPORATING GUIDANCE FROM REFS (D) THROUGH (U). IT WILL GUIDE INDIVIDUAL AND UNIT HEALTH PROTECTION, PRESERVE OPERATIONAL READINESS, AND PROTECT SHIPMATES, INSTALLATIONS, AND COMMUNITIES FROM COVID-19 TRANSMISSION. ALTHOUGH BIASED TOWARD THE SHIPBOARD ENVIRONMENT, THIS GUIDANCE APPLIES TO ALL PERSONNEL AND UNITS DEPLOYING TO AND FROM HOMEPORT (ORIGINATING UNIT LOCATION FOR RESERVE PERSONNEL) AS WELL AS ALL SHORE-BASED COMMANDS. IT DOES NOT APPLY TO ROUTINE TRAVEL (E.G. PCS, TDY, TAD) UNLESS THE TRAVELER IS A DEPLOYING INDIVIDUAL OR IS ASSIGNED TO OR WILL BE WORKING ABOARD AN OPERATIONAL UNIT (SPECIFICALLY IN PARA 3.B.2 AND 4.E). 1.B. ADHERENCE TO THIS GUIDANCE INCLUDES ACCOUNTING FOR SPECIFIC CIRCUMSTANCES INVOLVING CIVILIAN EMPLOYEES OR CONTRACTORS PER PARAGRAPH 10. 1.C. COMMANDERS. THERE IS NO SUBSTITUTE FOR COMMAND ENGAGEMENT TO SUCCESSFULLY PREVENT AND MITIGATE COVID-19 WITHIN YOUR UNIT. YOU SET THE TONE AND MUST CONVEY THE IMPORTANCE OF EACH SAILORS ACTION AND PERSONAL RESPONSIBILITY TO FOLLOW PUBLISHED HEALTH PROTECTION PROCEDURES BOTH ON AND OFF DUTY, PROPERLY EXECUTE ROM-SEQUESTER IF REQUIRED, AND HOLD THEMSELVES AND THEIR SHIPMATES ACCOUNTABLE FOR PERSONNEL AND MISSION READINESS. COMMAND ENGAGEMENT, CREW OWNERSHIP, INDIVIDUAL ACCOUNTABILITY AND DISCIPLINED COMPLIANCE WITH EFFECTIVE HEALTH PROTECTION MEASURES SUCH AS CLOTH FACE COVERING USE, SOCIAL DISTANCING, SELF -MONITORING FOR ILLNESS AND AGGRESSIVE SPACE CLEANING ARE THE GREATEST INFLUENCERS TO PREVENTING COVID-19 OUTBREAKS. SOME GENERAL OBSERVATIONS AND DISCUSSION POINTS FOR YOUR LEADERSHIP TEAMS FOLLOW: 1.C.1. [MOD] WE HAVE DEPLOYED MISSION READY CARRIER STRIKE GROUPS, DEFENSE SUPPORT OF CIVIL AUTHORITIES READY FORCES, STRATEGIC ASSETS AND INDEPENDENT UNITS WITHIN THE COVID-19 ENVIRONMENT. THE KEY ENABLER IS A DETAILED ROM-SEQUESTER PLAN EXECUTED WITH RIGOROUS DISCIPLINE, COMPLIANCE, AND LEADERSHIP OVERSIGHT. THE GOLD STANDARD OF SINGLE OCCUPANCY BARRACKS OR HOTEL ROOMS IS NOT ALWAYS ACHIEVABLE. WHEN A CREW IS REQUIRED TO ROM- SEQUESTER AT HOME, A DETAILED SUPPORT PLAN TO ELIMINATE THE NEED TO INTERACT WITH THE PUBLIC IS ESSENTIAL. ROM-SEQUESTER IN HOMES OR MULTIPLE OCCUPANCY BARRACKS HAS BEEN SUCCESSFUL, BUT ONLY WITH STRICT COMPLIANCE TO DETAILED HEALTH PROTECTION MEASURES. AS MORE UNITS HAVE ACCESS TO IMMUNIZATION PRIOR TO DEPLOYMENT, NCC COMMANDERS MAY ADJUST ROM SEQUESTER PLANS TO ACCOUNT FOR THOSE WHO HAVE BEEN IMMUNIZED. ADJUSTED ROM GUIDANCE IS LISTED IN PARA 3.B. 1.C.2. [MOD] TESTING CAN SUPPORT ROM-SEQUESTER RISK DECISIONS BUT TESTING RESOURCES ARE CONSTANTLY CONSTRAINED AND MAY BECOME MORE CONSTRAINED DURING THE HEIGHTENED COVID LEVELS ACROSS OUR NATION. DEVELOP A DETAILED PLAN EARLY AND COMMUNICATE CLEARLY AND REGULARLY UP ECHELON TO COORDINATE YOUR PLAN AND ENSURE YOU RECEIVE PROPER TESTING SUPPORT AT THE APPROPRIATE TIME. IAW REF (N) AND PARA 13, NON-DIAGNOSTIC TESTING FOR UNITS MUST BE REQUESTED 60 DAYS IN ADVANCE. HAVE A PLAN IF TEST RESULTS ARE DELAYED. DO NOT SECURE ROM-SEQUESTER FOR NON-IMMUNIZED INDIVIDUALS IF TEST RESULTS ARE DELAYED. LEAVING ROM-SEQUESTER WITHOUT WAITING FOR RESULTS IS A THREAT VECTOR DIRECTLY ATTRIBUTED TO COVID OUTBREAKS. BE READY TO DEVELOP AND EXECUTE A NEW PLAN. 1.C.3. TO DATE NEARLY EVERY SHIP IN THE NAVY HAS HAD AT LEAST ONE CASE ONBOARD. IN THE MAJORITY OF THOSE CASES, AGGRESSIVE EARLY ACTION TO ISOLATE, QUARANTINE, CONTACT TRACE, AND CONTINUE STRICT HEALTH PROTECTION MEASURES HAS CONTAINED THE INCIDENCE RATE ONBOARD TO WELL LESS THAN FIVE PERCENT, ALLOWING THOSE SHIPS TO FIGHT THROUGH AND REMAIN ON MISSION. WITH THE INTRODUCTION OF COVID VACCINES, THE RISK OF AN OUTBREAK IS FURTHER REDUCED. THE KEY ENABLERS ARE A HIGHLY IMMUNIZED CREW, STRICT COMPLIANCE WITH PERSONAL PROTECTIVE EQUIPMENT (PPE), AGGRESSIVE SANITATION/CLEANING, MINIMIZING CREW INTERACTIONS THROUGH SOCIAL DISTANCING, AND REDUCING USE OF CONFINED SPACES (E.G., GYMS, SMOKE PITS). 1.C.4. NUMEROUS STUDIES HAVE IDENTIFIED THE SPREADING AND CONTAGIOUS NATURE OF COVID-19 IS OVER-DISPERSED OR NOT SPREAD EVENLY. SAID ANOTHER WAY, A FEW INDIVIDUALS ACCOUNT FOR A LARGE PORTION OF SPREADING. SINCE IT IS NOT POSSIBLE TO IDENTIFY THESE HIGHLY CONTAGIOUS INDIVIDUALS (WHO MAY BE ASYMPTOMATIC), THE BEST WAY TO AVOID OR PREVENT SUPER-SPREADING CLUSTERS OF COVID-19 IS TO STAY AWAY FROM VENUES WITH PROLONGED CONTACT, POOR VENTILATION, AND CROWDING. THE MAJORITY OF THESE EVENTS OCCUR IN POORLY VENTILATED, CROWDED INDOOR ENVIRONMENTS WHERE MANY PEOPLE CONGREGATE OVER TIME. COMMANDERS SHOULD BE AWARE OF THESE FACTORS AND HOW THEY APPLY TO INDIVIDUAL UNITS WHILE OPERATING AND MAINTAINING THEIR SHIPS AND AIRCRAFT IN A COVID-19 ENVIRONMENT, BUT NOT AT THE EXPENSE OF SAFE AND EFFECTIVE OPERATIONS. STRICT ENFORCEMENT OF TYCOM STANDARD OPERATING PROCEDURES, USE OF PPE, AND PERSONAL RESPONSIBILITY MEASURES SUCH AS SOCIAL DISTANCING, MINIMIZING IN PERSON EVENTS, AND LIMITING TIME OF GROUP INTERACTIONS ARE HEALTH PROTECTION MEASURES THAT WILL REDUCE LIKELIHOOD OF VIRUS TRANSMISSION. 1.C.5. THE NAVY HAS EXPERIENCED A STRONG CORRELATION BETWEEN SAILOR RATES OF INFECTION AND THE RATE OF INFECTION IN THE LOCAL AREA. ROM-SEQUESTER CONOPS, LEAVE AND ALL TDY TRAVEL APPROVALS MUST ACCOUNT FOR LOCAL COMMUNITY TRANSMISSION RATES AS DIRECTED IN REF (C) AND MODIFIED BY REF (L). 1.C.6. [MOD] WITHIN THE UNIFORMED NAVY POPULATION, MANY INFECTED SAILORS EXHIBIT FEW TO NO SYMPTOMS. THOSE WHO ARE IMMUNIZED ARE EVEN LESS LIKELY TO EXHIBIT SYMPTOMS AND IF THEY DO EXPERIENCE SYMPTOMS, THEY ARE MILDER. THIS SHOULD BUILD CONFIDENCE IN A SHIPS ABILITY TO FIGHT THROUGH OUTBREAKS, BUT IT SHOULD ALSO STRESS THE NEED FOR STRICT ADHERENCE TO ROM-SEQUESTER PLANS AND TESTING. TESTING IS THE BEST WAY TO UNCOVER ASYMPTOMATIC SERVICE MEMBERS AMONG THE NON-IMMUNIZED OR TO GAIN CONFIDENCE THAT A BUBBLE STILL EXISTS. 1.C.7. [MOD] ASSUME COVID-19 IS ONBOARD. THIS SHOULD BE THE NUMBER ONE PLANNING FACTOR! AVOID FALSE CONFIDENCE, COMPLACENCY, AND COVID FATIGUE WHICH CAN RESULT FROM ROM-SEQUESTER, OVER CONFIDENCE IN NEGATIVE COVID-19 TESTING, UNKNOWNS DUE TO ASYMPTOMATIC INDIVIDUALS, AND PARTIALLY IMMUNIZED CREWS. EVEN AFTER THE RIGOROUS EXECUTION OF A 14-DAY ROM-SEQUESTER, CONTINUED EXECUTION OF FULL HEALTH PROTECTION MEASURES IS REQUIRED TO REDUCE THE RISK OF ASYMPTOMATIC CARRIERS CAUSING UNCONTROLLABLE OUTBREAKS. THIS INCLUDES CLOTH FACIAL COVERING USE, MANAGING THE CREW IN COHORTS, MINIMIZING THE TIME SPENT WITHIN 6 FEET OF OTHERS, MAXIMIZING DISTANCING WHENEVER AND WHEREVER POSSIBLE, AND AVOIDING UNNECESSARY CLOSE CONTACT WITH OTHERS. UNITS WITH A HIGH PERCENTAGE OF MEMBERS IMMUNIZED WILL GREATLY REDUCE THE PROBABILITY OF A WIDESPREAD OUTBREAK. 1.C.8. MAXIMIZE SEPARATION BETWEEN CARETAKER CREW (DUTY CREW DURING ROM-SEQUESTER PERIOD) AND OFF-SHIP ROM-SEQUESTER CREW TO PROTECT BOTH GROUPS. WE HAVE ACHIEVED TREMENDOUS SUCCESS IN DEPLOYING COVID-19 FREE WHEN THE CREW REMAINED SEQUESTERED FOR THE FULL 14 DAYS AND WERE NOT MIXED TOGETHER UNTIL NEGATIVE TEST RESULTS WERE CONFIRMED. 1.C.9. [MOD] BERTHING. SAILORS SHOULD ALTERNATE HEAD/FOOT WHERE BERTHING CONFIGURATION ALLOWS TO MINIMIZE CLOSE CONTACT. WHERE POSSIBLE, SPREAD OUT SLEEPING ARRANGEMENTS. IN CONGESTED BERTHINGS, ENSURE SAILORS USE PERSONAL PILLOWS AND LINENS ARE REGULARLY LAUNDERED. THIS IS A BEST PRACTICE THAT TRANSCENDS THE CORONAVIRUS DISEASE AND PROTECTS SAILORS AGAINST OTHER VIRAL OUTBREAKS. 1.C.10. COMMANDERS MUST UNDERSTAND THE CURRENT HPCON LEVEL. HPCON LEVELS WILL REMAIN DYNAMIC, AS LOCAL AREAS STRUGGLE TO MAINTAIN PACE WITH THIS ELUSIVE THREAT. INDIVIDUAL SAILORS AND COMMANDS MUST SHOW RESOLVE IN PRACTICING PROPER HEALTH PROTECTION MEASURES AND AVOID UNNECESSARY RISK. ADDITIONALLY, LIBERTY AND ALL TEMPORARY DUTY TRAVEL APPROVAL PRIOR TO ROM-SEQUESTER MUST BE WEIGHED AGAINST RISK OF CONTRACTING COVID. THIS IS ESPECIALLY TRUE IF COVID-FREE WITH A PORT CALL BETWEEN AT-SEA PERIODS. REF (C) AS MODIFIED BY REF (L) PROVIDES DETAILED TRAVEL APPROVAL GUIDANCE. 1.C.11. FACE COVERINGS WITH AN EXHAUST VALVE AND BANDANNAS ARE PROHIBITED. THESE TYPE OF FACE COVERINGS DO NOT ENTRAIN MOISTURE IN EXHALED BREATH, FAILING TO REDUCE THE SPREAD OF THE COVID-19 VIRUS AND FAILING TO PROTECT OTHER PERSONNEL. 1.C.12. COMMANDS MAY ISSUE LOCAL GUIDANCE AUTHORIZING USE OF MULTI-LAYER NECK GAITERS MEETING REF (M) AND ALL SAFETY REQUIREMENTS WHERE A SEPARATE EAR STRAP OR NECK STRAP FACE COVERING IS NOT SUITABLE FOR THE OPERATIONAL ENVIRONMENT. 1.D. THE ECHELON TWO AND NAVAL COMPONENT COMMANDERS (NCC) ARE THE WAIVER AUTHORITY TO DEVIATE FROM THIS GUIDANCE. 1.E. CONTENTS. PARAGRAPH 2 DEFINITIONS. PARAGRAPH 3 MINIMUM ACTION REQUIRED PRIOR TO DEPLOYED OPERATIONS. 3.A. MEDICAL SCREENING. 3.B. ROM-SEQUESTER PRIOR TO DEPLOYMENT. 3.C. DEPLOYING UNITS. 3.D. SHIP RIDERS PRIOR TO BUBBLE ESTABLISHMENT. 3.E. SHIP RIDERS PENETRATING SHIP BUBBLE. PARAGRAPH 4 MINIMUM REQUIRED ACTION FOR MAINTENANCE, BASIC, ADVANCED/INTEGRATED, AND SUSTAINMENT PHASES. 4.A. MAINTENANCE PHASE. 4.B. BASIC/ADVANCED PHASE. 4.C. INTEGRATED PHASE. 4.D. SUSTAINMENT PHASE. PARAGRAPH 5 GUIDANCE FOR FORWARD DEPLOYED NAVAL FORCES. PARAGRAPH 6 EXEMPTIONS FOR AIRCREW AND AIRCRAFT MAINTAINERS. PARAGRAPH 7 REQUIRED ACTION WHEN MEMBER EXHIBITS SYMPTOMS OF COVID-19. 7.A. ISOLATE AND DESIGNATE AS A PERSON UNDER INVESTIGATION (PUI). 7.B. IDENTIFY, QUARANTINE CLOSE CONTACTS. 7.C. PUI PROTOCOL. 7.D. RETURN TO WORK (RTW) GUIDANCE. PARAGRAPH 8 UNDERWAY TESTING. PARAGRAPH 9 POST-DEPLOYMENT/REDEPLOYMENT. PARAGRAPH 10 OUTBREAK INVESTIGATION AND CONTACT TRACING WORKFORCE TRAINING. PARAGRAPH 11 ADDITIONAL ROM AND MEDICAL SCREENING CONSIDERATIONS. PARAGRAPH 12 VACCINATION. PARAGRAPH 13 TESTING AND REPORTING REQUIREMENTS. PARAGRAPH 14 COMMUNITY OUTREACH GUIDANCE. 2. DEFINITIONS. 2.A. COVID-19 CASE: A MEMBER DESIGNATED BY A MEDICAL PROVIDER BY ONE OF TWO METHODS: 1) A POSITIVE COVID-19 LABORATORY TEST (CONFIRMED CASE), OR 2) ASSESSED AS PRESUMED POSITIVE PER THE COUNCIL OF STATE AND TERRITORIAL EPIDEMIOLOGIST (CSTE) CRITERIA FOR A PROBABLE CASE. 2.B. PATIENT (OR PERSON) UNDER INVESTIGATION (PUI): AN INDIVIDUAL WITH SIGNS OR SYMPTOMS OF COVID-19 WHO HAS A TEST RESULT PENDING OR WOULD HAVE BEEN TESTED HAD A TEST BEEN AVAILABLE. ASYMPTOMATIC INDIVIDUALS QUARANTINED DUE TO CLOSE CONTACT WITH A COVID-19 POSITIVE MEMBER ARE NOT CLASSIFIED AS PUIS. ASYMPTOMATIC INDIVIDUALS BEING TESTED FOR COVID-19 ARE NOT CONSIDERED PUIS WHILE AWAITING TEST RESULTS. 2.B.1. [MOD] PUIS WHO RECEIVE A POSITIVE POLYMERASE CHAIN REACTION (PCR) COVID-19 LAB TEST RESULT ARE CONSIDERED A CONFIRMED COVID-19 CASE AND APPROPRIATE REPORTING SHOULD TAKE PLACE. 2.B.2. MEMBERS ARE NO LONGER CONSIDERED PUIS WHEN THEY RECEIVE A NEGATIVE COVID-19 LAB TEST RESULT OR HAVE MET ALL CRITERIA FOR RETURN TO WORK OUTLINED IN PARAGRAPH 7.D. 2.C. HIGH-RISK PERSONNEL: THOSE INDIVIDUALS, DESIGNATED BY A MEDICAL PROVIDER, THAT MEET THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) CRITERIA FOR INCREASED RISK OF SEVERE ILLNESS FROM COVID-19 AVAILABLE AT: HTTPS://WWW.CDC.GOV/CORONAVIRUS/2019-NCOV/NEED-EXTRA- PRECAUTIONS/PEOPLE-AT -HIGHER-RISK.HTML. THIS LIST EVOLVES AS KNOWLEDGE OF COVID-19 GROWS AND SHOULD BE CHECKED FREQUENTLY. 2.C.1. OPERATIONALLY AT-RISK PERSONNEL: THOSE INDIVIDUALS, DESIGNATED BY OPERATIONAL COMMANDERS, WHOSE DUTIES PLACE THEM AT A HIGHER RISK OF EXPOSURE TO THE VIRUS, THEREBY INCREASING THE LIKELIHOOD OF INTRODUCING COVID-19 INTO A BUBBLE. EXPOSURE CAN OCCUR WHEN PARTICIPATING IN OPERATIONS, ACTIVITIES, AND PORT CALLS IN COUNTRIES WITH ACTIVE COVID-19 CASES, ENGAGING WITH PERSONNEL FROM COUNTRIES WITH ACTIVE COVID-19 CASES, AND OPERATIONS THAT MAY RESULT IN ENVIRONMENTAL AND PERSON-TO- PERSON TRANSMISSION, SUCH AS REPLENISHMENT AT SEA AND FOOD SERVICE. 2.D. [MOD] CLOSE CONTACT: INDIVIDUALS IDENTIFIED AS BEING WITHIN APPROXIMATELY 6 FEET (2 METERS) OF A COVID-19 CASE FOR A PROLONGED PERIOD OF TIME. CDC GUIDANCE DEFINES PROLONGED PERIOD OF TIME AS A CUMULATIVE FIFTEEN MINUTES DURING A SINGLE TWENTY-FOUR HOUR PERIOD IN THE 48 HOURS PRIOR TO SYMPTOM ONSET OR FIRST POSITIVE TEST IF ASYMPTOMATIC UNTIL THE TIME THE PERSON WAS PLACED IN ISOLATION. CLOSE CONTACT CAN OCCUR WHILE CARING FOR, LIVING WITH, VISITING, WORKING WITH, OR SHARING A DENSELY POPULATED SPACE WITH A COVID-19 CASE. CLOSE CONTACT CAN ALSO BE ESTABLISHED VIA DIRECT CONTACT (E.G., BEING COUGHED OR SNEEZED UPON BY A COVID-19 CASE). UNDER THESE CIRCUMSTANCES, AN INDIVIDUAL IS CONSIDERED A CLOSE CONTACT EVEN IF THEY WERE WEARING A CLOTH FACE COVERING. SOME EXAMPLES SPECIFIC TO THE SHIPBOARD ENVIRONMENT INCLUDE: A) INDIVIDUALS WITHIN THE COVID-19 CASE BERTHING AREA ASSIGNED AN ADJACENT RACK INCLUDING DIRECTLY ACROSS A NARROW AISLE; B) PROLONGED INTERACTION WITHIN RELATIVELY CONFINED SPACES INTERNAL TO THE SHIP (E.G. WORK SPACE, GALLEY, GYM, SMOKING DECK, CHAPEL, ETC). VACCINATED AND IMMUNIZED INDIVIDUALS WILL BE CONSIDERED A CLOSE CONTACT FOR CONTACT TRACING PURPOSES. REFER TO PARA 7.B FOR ACTIONS TO TAKE FOR CLOSE CONTACTS. 2.E. MEDICAL SCREENING: COVID-19 MEDICAL SCREENING SHOULD INCLUDE EVALUATION FOR THE FOLLOWING SYMPTOMS: FEVER OR CHILLS, COUGH, SHORTNESS OF BREATH OR DIFFICULTY BREATHING, FATIGUE, MUSCLE OR BODY ACHES, HEADACHE, NEW LOSS OF TASTE OR SMELL, SORE THROAT, CONGESTION OR RUNNY NOSE, NAUSEA OR VOMITING, AND DIARRHEA. A COMPLETE LIST OF COVID-19 SYMPTOMS CAN BE FOUND AT: HTTPS://WWW.CDC.GOV/CORONAVIRUS/ 2019-NCOV/SYMPTOMS-TESTING/SYMPTOMS.HTML. THE FLU AND COVID VACCINES CAN BE ASSOCIATED WITH MILD SIDE EFFECTS SUCH AS SORENESS, REDNESS OR SWELLING AT THE INJECTION SITE, LOW GRADE FEVER AND BODY ACHES. THESE SYMPTOMS COULD BE CONFUSED WITH COVID LIKE SYMPTOMS SO HISTORY OF VACCINATION SHOULD BE CONSIDERED WHEN EVALUATING COVID LIKE SYMPTOMS. 2.F. SELF-MONITORING: PER THE CDC, SELF-MONITORING INCLUDES ASSESSING FOR COVID-19 SYMPTOMS PER PARAGRAPH 2.E. INDIVIDUALS THAT DEVELOP COVID-19 SYMPTOMS SHOULD IMMEDIATELY SELF-ISOLATE, AVOID CONTACT WITH OTHERS, AND SEEK ADVICE FROM A HEALTHCARE PROVIDER TO DETERMINE IF FURTHER MEDICAL EVALUATION IS REQUIRED. 2.G. RESTRICTION OF MOVEMENT (ROM). GENERAL DOD TERM FOR LIMITING PERSONAL INTERACTION TO REDUCE RISK TO THE HEALTH, SAFETY AND WELFARE OF A BROADER COHORT. ROM IS USED TO MINIMIZE RISK OF INDIVIDUALS ENCOUNTERING COVID-19 CONTAGIOUS INDIVIDUALS, AND TO PREVENT PERSONNEL WHO HAVE BEEN IN A HIGHER RISK AREA FROM POTENTIALLY INFECTING OTHERS. ROM INCLUDES ISOLATION, QUARANTINE AND ROM-SEQUESTER. PERSONNEL EXECUTING A ROM ARE CONSIDERED TO BE IN A DUTY STATUS AND ROM PERIODS WILL NOT BE COUNTED AS ANNUAL LEAVE. 2.G.1. ISOLATION: MEDICAL TERM FOR THE STRICT SEPARATION OF PERSONNEL FROM OTHERS DUE TO THE DEVELOPMENT OF POTENTIAL OR PROVEN COVID-19 SYMPTOMS OR A POSITIVE COVID-19 TEST. 2.G.2. [MOD] QUARANTINE: MEDICAL TERM FOR SEPARATING THOSE ASYMPTOMATIC PEOPLE REASONABLY BELIEVED TO HAVE BEEN EXPOSED TO A COMMUNICABLE DISEASE IN ORDER TO PREVENT THE POSSIBLE SPREAD OF THE COMMUNICABLE DISEASE. FOR THE COVID-19 PANDEMIC, PERSONNEL WITH NO COVID-19 SYMPTOMS WHO HAVE RECENTLY RETURNED FROM A HIGHER RISK LOCATION OR HAD CLOSE CONTACT WITH A KNOWN COVID-19 POSITIVE PATIENT SHOULD BE QUARANTINED. THE QUARANTINE PERIOD FOR INDIVIDUALS ASSIGNED TO OPERATIONAL UNITS IS 14-DAYS (NCCS MAY DETERMINE WHICH UNITS ARE OPERATIONAL AND NON OPERATIONAL BASED ON PHASE OF OFRP SCHEDULE AND EMPLOYMENT). IAW REF (E), FOR ASYMPTOMATIC INDIVIDUALS ASSIGNED TO NON-OPERATIONAL UNITS AND STAFFS, COMMANDERS HAVE THREE OPTIONS FOR QUARANTINE DURATION BASED ON WORK ENVIRONMENT AND CIRCUMSTANCES OF CLOSE CONTACT: (1) QUARANTINE 14 DAYS (2) QUARANTINE 10 DAYS WITH COMMANDERS RISK ASSESSMENT OR (3) QUARANTINE 7 DAYS WITH A NEGATIVE TEST. FOLLOWING 7 OR 10 DAY QUARANTINE, INDIVIDUALS SHOULD WATCH FOR SYMPTOMS UNTIL 14 DAYS AFTER EXPOSURE AND IMMEDIATELY SELF-ISOLATE IF THEY DEVELOP SYMPTOMS. QUARANTINE OPTIONS (2) AND (3) RESULT IN HIGHER POST-QUARANTINE TRANSMISSION RISKS THAN OPTION (1). PERSONNEL WHO HAVE TESTED POSITIVE FOR COVID-19 DO NOT NEED TO QUARANTINE OR GET TESTED AGAIN FOR UP TO 3 MONTHS AS LONG AS THEY DO NOT DEVELOP SYMPTOMS AGAIN. THIS EXCEPTION IS DUE TO THE LIKELIHOOD OF SOME IMMUNITY DEVELOPING AFTER INFECTION AND THE PRESENCE OF DEAD VIRAL FRAGMENTS THAT ARE NO LONGER CONTAGIOUS BUT WILL LIKELY YIELD A POSITIVE TEST RESULT. IAW CDC GUIDANCE ALL IMMUNIZED PERSONNEL (GREATER THAN TWO WEEKS AFTER FINAL DOSE OF VACCINE) WHO RECEIVED THEIR LAST DOSE WITHIN THE PAST THREE MONTHS AND HAVE REMAINED ASYMPTOMATIC DO NOT NEED TO QUARANTINE IF THEY ARE A CLOSE CONTACT, BUT MUST FOLLOW STRICT HEALTH PROTECTION MEASURES. 2.G.3. ROM-SEQUESTER: U.S. NAVY TERM FOR PREEMPTIVE SEPARATION OF FORCES TO REDUCE RISK OF INFECTION WHILE ATTEMPTING TO ESTABLISH A COVID-FREE BUBBLE. ROM-SEQUESTER CAN BE CONDUCTED ONBOARD SHIP, IN CONTRACTED FACILITIES, OR IN PERSONAL RESIDENCE DEPENDENT ON UNIT- SPECIFIC SCENARIOS. DURING ROM-SEQUESTER, INTERACTION WITH INDIVIDUALS MUST BE MINIMIZED, BY NECESSITY ONLY WITH ALL HEALTH PROTECTION MEASURES IMPLEMENTED. ASSUME EVERYONE HAS COVID. INTERACTION WITHIN ROM-SEQUESTER LOCATION IS RESTRICTED TO NECESSITIES SUCH AS FOOD DELIVERY, HEALTH AND WELFARE CHECKS, ETC. 2.H. BUBBLE: TERM FOR INDIVIDUALS, UNITS OR INSTALLATIONS THAT HAVE ESTABLISHED LOW PROBABILITY OF COVID-19 INFECTION. A CREW THAT HAS BEEN UNDERWAY, OR ROM-SEQUESTERED, FOR GREATER THAN 14 DAYS WITHOUT COVID-19 POSITIVE PERSONNEL AND NO COVID-19 SYMPTOMS IS CONSIDERED TO BE WITHIN A BUBBLE. 2.I. BUBBLE TO BUBBLE TRANSFER (B2BT): TERM FOR MOVEMENT OF UNITS OR PERSONNEL FROM ONE BUBBLE TO ANOTHER VIA CONTROLLED MEANS. A WIDE VARIETY OF MODES OR MEANS OF TRANSPORTATION CAN BE USED FOR B2BT. THE KEY FACTOR IS THAT THE EVOLUTION IS CLOSELY CONTROLLED TO MINIMIZE RISK OF COVID-19 EXPOSURE TO BOTH INDIVIDUALS AND UNITS WHO HAVE NOT COMPLETED A ROM-SEQUESTER DURING TRANSFER. 2.J. TESTING: GENERAL TERM FOR THE INTENDED USE OF REAGENTS, SUPPLIES, AND EQUIPMENT TO DETECT THE PRESENCE OF SARS-COV-2, THE VIRUS THAT CAUSES COVID-19, IN SAMPLES COLLECTED FROM INDIVIDUALS. 2.J.1. DIAGNOSTIC TESTING: USE OF AN APPROVED TEST BY CERTIFIED LABORATORIES, TO INCLUDE SHIPBOARD CERTIFIED LABS, TO DIAGNOSE COVID-19 INFECTION IN AN INDIVIDUAL SUSPECTED OF BEING INFECTED. INDIVIDUALS SUSPECTED OF BEING INFECTED INCLUDE SYMPTOMATIC INDIVIDUALS WHO PRESENT TO A HEALTHCARE PROVIDER, AND INDIVIDUALS IDENTIFIED THROUGH CONTACT TRACING. 2.J.2. [MOD] SCREENING TESTING: TESTING OF A POPULATION OR INDIVIDUAL THAT IS USED TO RAPIDLY IDENTIFY UNRECOGNIZED DISEASE (ASYMPTOMATIC PERSONS). SCREENING TESTS ARE NOT MEANT TO BE DIAGNOSTIC. SCREENING TESTS ARE USED TO INCREASE THE LIKELIHOOD THAT THE ENTIRE POPULATION OR AN AT RISK SUB-POPULATION IS CLEAR OF INFECTION. TYPICALLY DONE IN CONJUNCTION WITH A RESTRICTION OF MOVEMENT TO ENSURE THE POPULATION DID NOT HAVE AN OPPORTUNITY TO BECOME INFECTED OR THE INFECTION HAD RUN ITS COURSE PRIOR TO BRINGING A GROUP TOGETHER. MAY ALSO BE USED TO TEST CRITICAL WATCHSTANDERS UNDERWAY WHEN AN INFECTION IS SUSPECTED OR IDENTIFIED IN THE GROUP. 2.J.3. SURVEILLANCE TESTING: TESTING OF RANDOM PORTIONS OF A POPULATION TO SEARCH FOR AND IDENTIFY POTENTIAL SPREAD OF ASYMPTOMATIC COVID-19 INFECTIONS. SURVEILLANCE TESTING DOES NOT IDENTIFY RESULTS TO A SPECIFIC INDIVIDUAL. 2.J.4. NAVY SENTINEL SURVEILLANCE TESTING IS THE NAVY TESTING PROGRAM TO SURVEIL APPROXIMATELY ONE PERCENT OF THE TOTAL NAVY MANPOWER AND APPROXIMATELY 10 PERCENT OF HEALTHCARE WORKERS ON A BI-WEEKLY BASIS, AS TESTING SUPPLIES AND CAPACITY SUPPORT. 2.K. [MOD] INFLUENZA LIKE ILLNESS (ILI): PER CDC, ILI IS DEFINED AS FEVER (TEMPERATURE OF 100.4 DEGREES F [37.8 DEGREES C] OR GREATER) AND A COUGH AND/OR A SORE THROAT WITHOUT A KNOWN CAUSE. A PERSON MAY BE CONTAGIOUS FOR UP TO 7 DAYS WITH THE FLU. THERE ARE NO DEFINITIVE SYMPTOMS THAT CAN BE USED AS DISCRIMINATORS TO DIAGNOSE AN INFECTION AS FLU ONLY AND NOT COVID OR RULE OUT CO-INFECTION. INFECTION WITH FLU DOES NOT PRECLUDE OR REDUCE THE GENERAL PROBABILITY THAT COVID INFECTION IS PRESENT. MANY CASES OF CO-INFECTION HAVE OCCURRED. IT MAY NOT BE POSSIBLE TO DISCRIMINATE BETWEEN THE FLU AND COVID-19. THE RISK OF CO-INFECTION EMPHASIZES THE NEED TO ENSURE INFLUENZA VACCINATION IS COMPLETED AS SOON AS POSSIBLE. 2.L. [MOD] POOLED TESTING: TESTING APPROACH COMBINING INDIVIDUAL SAMPLES TO TEST PRESENCE OF INFECTION IN THE COMBINED POOL. USED IN A SCREENING OR SURVEILLANCE STRATEGY TO EXPAND A LABORATORY CAPACITY TO PERFORM SARS-COV-2 TESTING. POOLED TESTING FACILITATES DETERMINATION OF POPULATION HEALTH WHILE CONSERVING TESTING RESOURCES. DO NOT POOL TEST IMMUNIZED PERSONNEL. 2.M. [NEW] VACCINATED: AN INDIVIDUAL WHO HAS RECEIVED THE FIRST SHOT IN A SERIES OF TWO SHOTS OF COVID-19 VACCINE. WHILE NOT USED IN THE TRADITIONAL MEDICAL CONTEXT, THE TERMS VACCINATED AND IMMUNIZED WILL BE USED TO DIFFERENTIATE THOSE WHO HAVE RECEIVED 1 OR 2 DOSES, RESPECTIVELY. 2.N. [NEW] IMMUNIZED: AN INDIVIDUAL WHO HAS COMPLETED THE VACCINE SERIES AND IS CONSIDERED IMMUNE (TO THE LEVEL OF EFFICACY OF THE VACCINE) **AT LEAST TWO WEEKS POST SECOND VACCINE**. NO VACCINE IS 100% EFFECTIVE AND THERE IS STILL A CHANCE AN INDIVIDUAL CAN BECOME INFECTED, BUT RECEIVING THE VACCINE SIGNIFICANTLY REDUCES THE RISK OF SYMPTOMATIC INFECTION AND SEVERE ILLNESS. INDIVIDUALS ARE HIGHLY ENCOURAGED TO RECEIVE THE VACCINE TO PROTECT THEMSELVES FROM INFECTION. NOTE: IT IS LIKELY THAT THERE WILL SOON BE COMMERCIALLY AVAILABLE COVID-19 VACCINES WHOSE FDA EMERGENCY USE AUTHORIZATION ONLY REQUIRES A SINGLE DOSE. IN THAT SCENARIO, TWO WEEKS FOLLOWING THE SINGLE DOSE WOULD MEET THE DEFINITION OF IMMUNIZED. 2.O. [NEW] DEFERRED: AS ANNOTATED IN THE MEDICAL READINESS REPORTING SYSTEM, AN INDIVIDUAL WHO WAS OFFERED THE VACCINE BUT DECLINED OR HAD A MEDICAL CONTRAINDICATION OR TEMPORARY REASON TO NOT RECEIVE THE VACCINE IS CONSIDERED DEFERRED. THESE INDIVIDUALS ARE ALLOWED TO CHOOSE, AT ANY TIME, TO RECEIVE THE VACCINE IF IT IS AVAILABLE. AFTER RECEIVING A VACCINE DOSE, AN INDIVIDUAL WILL NO LONGER BE LISTED AS DEFERRED. 2.P. [NEW] AFLOAT MTF: AS UTILIZED IN THIS SOG TO TREAT COVID-19 AND BE AN AFLOAT MTF (PARA 3.C.1), MEDICAL CAPABILITY ON CVN/LHA/LHD/T-AH PLATFORMS SHALL BE CAPABLE OF ORGANICALLY TREATING ADVERSE COVID-19 REACTIONS UNDERWAY WITH BASIC LIFE SUPPORT (BLS), ADVANCED CARDIAC LIFE SUPPORT, A PRIVILEGED CLINICIAN CAPABLE OF TREATING A CRITICALLY ILL PATIENT IN AN INTENSIVE CARE UNIT (SUCH AS A FAMILY MEDICINE, INTERNAL MEDICINE, CRITICAL CARE MEDICINE PHYSICIAN OR GENERAL SURGEON), A CRITICAL CARE NURSE, AN ANESTHESIA PROVIDER, A LABORATORY TECHNICIAN AND A RADIOLOGY TECHNICIAN. REQUIRED EQUIPMENT INCLUDES ICU BEDS (TO INCLUDE MONITORS, IV PUMPS AND VENTILATORS), GENERAL WARD BEDS, A FUNCTIONING LABORATORY AND X-RAY, SUFFICIENT OXYGEN TANK STORES AND A PROPERLY STOCKED PHARMACY TO INCLUDE CRITICAL CARE MEDICINES (TO INCLUDE THOSE TO TREAT ANAPHYLAXIS SUCH AS EPINEPHRINE AND DIPHENHYDRAMINE). SAFE MEDEVAC AS NEEDED. FOR THE TREATMENT OF SEVERELY ILL COVID-19 PATIENTS UNTIL MEDEVAC IS AVAILABLE, REQUIREMENTS IN ADDITION TO THE CRITICAL CARE REQUIREMENTS ABOVE WOULD BE AN OPERATING ROOM, GENERAL SURGEON (E.G. TO OPEN A SURGICAL AIRWAY) AND ADDITIONAL COVID-19 DIAGNOSTIC CAPABILITY (ORGANIC SARS-COV-2 TESTING CAPABILITY) AND TREATMENTS SUCH AS STEROIDS, REMDESIVIR, AND COVID-19 CONVALESCENT PLASMA. 3. MINIMUM ACTION REQUIRED PRIOR TO DEPLOYED/DSCA READY FORCE OPERATIONS. 3.A. MANDATORY MEDICAL SCREENING BY A MEDICAL PROVIDER. 3.A.1. PRE-DEPLOYMENT SCREENING FOR ALL PERSONNEL WILL CONSIST OF AN ASSESSMENT OF COVID-19 EXPOSURE HISTORY, A TEMPERATURE CHECK, A CHECK FOR COVID-19 SIGNS AND SYMPTOMS LISTED IN PARA 2.E. FOR MILITARY MEMBERS, IT WILL ALSO INCLUDE A REVIEW OF ANY PAST COVID-19 TESTING AND A THOROUGH EVALUATION OF THE MEMBERS RISK FACTORS FOR SEVERE ILLNESS FROM COVID-19. 3.A.2. [MOD] DEPLOYMENT OF HIGH-RISK INDIVIDUALS SHOULD BE UNCOMMON AND GUIDED BY MEDICAL RECOMMENDATIONS FOUND IN REF (H). THE DECISION TO DEPLOY THE INDIVIDUAL MUST BE MADE, AT A MINIMUM, BY THE ISIC. MILITARY SEALIFT COMMAND (MSC) WILL MEDICALLY SCREEN CIVIL SERVICE AND CONTRACT PERSONNEL FOR DEPLOYMENT ON MSC VESSELS IN ACCORDANCE WITH EXISTING MSC INSTRUCTIONS AND CONTRACTS. COMMANDERS ARE ENCOURAGED TO INCORPORATE IMMUNIZATION IN THEIR DECISION TO DEPLOY HIGH RISK PERSONNEL AND SHOULD BASE DECISION ON THE PERCENT OF THE UNIT IMMUNIZED, THE PROXIMITY TO A MTF OR AFLOAT MEDICAL FACILITY WITH COVID THERAPEUTICS AND ICU CAPABILITIES, AND MEDICAL PROVIDER CONSULTATION. 3.B. [NEW] ROM-SEQUESTER FOR SHIPS, SUBMARINES AND ORGANIC SQUADRONS. FOR IMMUNIZED INDIVIDUALS, ROM-SEQUESTER IS NOT REQUIRED. A HOME TO WORK SCHEDULE MINIMIZING EXTERNAL CONTACT SHOULD BE EMPLOYED VICE PRE-DEPLOYMENT ROM-SEQUESTER. FOR NON-IMMUNIZED INDIVIDUALS, CONDUCT A MINIMUM 14-DAY ROM-SEQUESTER WITH TEST-IN TEST-OUT PRIOR TO DEPLOYMENT. DEPENDING ON SCHEDULED AND PLANNED OPERATIONS, THE NCC WILL DETERMINE IF ROM-SEQUESTER IS REQUIRED PRIOR TO INTEGRATED PHASE. 3.B.1. CONDUCT ENHANCED DAILY PERSONNEL MEDICAL SCREENING (QUESTIONNAIRE AND TEMPERATURE CHECKS). 3.B.2. [MOD] ROM SEQUESTER PRIOR TO DEPLOYMENT FOR OTHER MEANS OF TRANSPORTATION. PERSONNEL DEPLOYING OUTSIDE THE UNITED STATES WILL UNDERGO A 14-DAY ROM-SEQUESTER PRIOR TO DEPLOYMENT UNLESS COMBATANT COMMAND MANDATES IN-COUNTRY ROM. IAW REF (Q), NCC MAY DELEGATE TO FIRST FLAG OFFICER/SES IN CHAIN OF COMMAND THE AUTHORIZATION TO REDUCE THIS ROM TIMELINE TO AS FEW AS 7 DAYS IF OPERATIONALLY NECESSARY WITH A NEGATIVE PCR TEST ADMINISTERED NO EARLIER THAN 5 DAYS AFTER START OF ROM. INDIVIDUALS WHO HAVE HAD COVID-19 IN THE PAST 3 MONTHS ARE EXEMPT FROM ROM. IF TRAVELING OCONUS AND THE HOST NATION REQUIRES 14-DAY IN-COUNTRY ROM, CONUS PRE-DEPLOYMENT ROM-SEQUESTER IS NOT REQUIRED UNLESS THE HOST NATION OR COMBATANT COMMAND EXPLICITLY MANDATES BOTH. CONSULT FOREIGN CLEARANCE GUIDANCE FOR MOST CURRENT REQUIREMENTS APPLICABLE TO ALL TRAVELERS, AVAILABLE AT HTTPS://WWW.FCG.PENTAGON.MIL. 3.B.3. [MOD] ACCEPTABLE ROM-SEQUESTER FACILITIES FOR NON-IMMUNIZED SAILORS ARE: SHIP BERTHING, LIVING BARGE, BARRACKS/HOTEL ROOMS, OR PERSONAL RESIDENCE (LIMITED CONTACT WITH OTHER RESIDENTS). EACH HAS PROS AND CONS THAT MUST BE WEIGHED AGAINST UNIT-SPECIFIC CIRCUMSTANCES AND RISK. MINIMIZING CONTACT WITH OTHERS AND FOLLOWING HEALTH PROTECTION MEASURES IS CRITICAL TO SUCCESSFUL ROM-SEQUESTER. 3.B.4. PRACTICE SOCIAL DISTANCING AND SANITIZE MORE FREQUENTLY WHILE MANNING ESSENTIAL WATCH STATIONS, COMPLETING REQUIRED MAINTENANCE, AND CONDUCTING REQUIRED UNDERWAY PREPARATION (LOGISTICS, TRAINING, ETC.). 3.B.5. [MOD] DEVELOP OPERATIONAL BENCH FOR REDLINE PERSONNEL THROUGH UNIT TRAINING AND QUALIFICATION PROGRAMS TO MAINTAIN MISSION ESSENTIAL OPERATIONS (NUCLEAR POWER PLANT, BRIDGE, COMBAT INFORMATION CENTER, CWC WATCHES, MEDICAL PROVIDERS, ETC). REDLINE PERSONNEL SHOULD BE PRIORITIZED FOR IMMUNIZATION. 3.C. [NEW] DEPLOYING UNITS. ROM-SEQUESTER PER FLEET APPROVED COMMUNITY CONOPS. FOR NON-IMMUNIZED SAILORS, ROM-SEQUESTERS WILL BE A MINIMUM OF 14 DAYS IN LENGTH AND REQUIRE TEST-IN AND TEST-OUT. ROM SEQUESTER IN NON-CONGREGATE FACILITIES MAY COMMENCE PRIOR TO RECEIVING A NEGATIVE TEST RESULT. PREVIOUSLY POSITIVE INDIVIDUALS WITHIN PAST (3) MONTHS SHOULD NOT BE RETESTED. NCC COMMANDERS MAY ADJUST ROM SEQUESTER PLANS TO ACCOUNT FOR THOSE WHO HAVE BEEN IMMUNIZED. 3.C.1 [NEW] 100% FULLY IMMUNIZED CREWS. FOR CREWS WHO ARE 100% IMMUNIZED, REFS (T) AND REF (U) MODELING SHOWS THE RISK OF INFECTION IS EXTREMELY LOW. ON THE CHANCE AN IMMUNIZED INDIVIDUAL CONTRACTS COVID-19, THE VACCINES SIGNIFICANTLY REDUCE THE RISK OF A NEGATIVE OUTCOME. THEREFORE, ROM-SEQUESTER IS NOT REQUIRED. MEDIUM SIZED UNITS (300-999) SHOULD OPERATE WITHIN 72 HOURS OF AN MTF OR AFLOAT MTF THE FIRST 4 DAYS AT SEA ON THE REMOTE CHANCE AN IMMUNIZED INDIVIDUAL HAS COVID-19. SMALLER UNITS (<300) MAY PROCEED IMMEDIATELY ON MISSION BASED ON VERY LOW RISK OF AN IMMUNIZED INDIVIDUAL HAVING COVID-19 IN THESE SMALLER POPULATIONS. IN ORDER TO IMPROVE OPERATIONAL EFFICIENCY, FULLY IMMUNIZED CREWS MAY RELAX HEALTH PROTECTION MEASURES AT 14 DAYS (CREW SIZE GREATER THAN 1,000), 4 DAYS (CREW SIZE 300-999) AND AFTER 1 DAY (CREW SIZE LESS THAN 300). FOR FULLY IMMUNIZED CREWS, ALL HEALTH PROTECTION MEASURES CONTINUE TO BE REQUIRED IF NON-IMMUNIZED INDIVIDUALS PENETRATE THE IMMUNIZED UNIT AND FOR ALL IMMUNIZED UNIT PERSONNEL INTERACTING WITH NON-IMMUNIZED PERSONNEL WHILE ONBOARD. FULL HPM ARE REQUIRED ASHORE. 3.C.2. [MOD] ROM-SEQUESTER CONDUCTED ASHORE: REQUIRES ISOLATION PER CDC GUIDANCE (IDEALLY SEPARATE ROOM, NO SHARED BATHROOM). A SECOND TEST SHALL BE CONDUCTED ON OR AFTER DAY 14 FOR NON-IMMUNIZED PERSONNEL. A NEGATIVE COVID TEST RESULT IS REQUIRED TO EMBARK IF NON-IMMUNIZED. 3.C.3. ROM-SEQUESTERS CONDUCTED ONBOARD A VESSEL OR IN A GROUP SETTING ASHORE (I.E., NOT ISOLATED PER CDC GUIDANCE): THE NCC WILL DIRECT EXACT TIMING OF THE SECOND TEST, BUT THE SECOND TEST SHALL BE NO EARLIER THAN DAY SEVEN. SERVICE MEMBERS TESTING POSITIVE WILL BE IMMEDIATELY ISOLATED TO MITIGATE COVID-19 VIRUS SPREAD. 3.C.4. [MOD] THE NCC (COMMANDER MSC FOR CIVIL SERVICE AND CONTRACT MARINERS) MAY APPROVE DEVIATIONS TO ROM-SEQUESTER PLANS DUE TO EMERGENT TASKING, TESTING LIMITS OR A HIGH PERCENTAGE OF IMMUNIZED CREW IAW REF (T) AND REF (U). THE NCC CAN ALSO ELECT TO BE MORE RESTRICTIVE IN THEIR TESTING PROTOCOLS PROVIDED TESTING CAPACITY SUPPORTS. 3.C.5. TESTING IS THE BEST WAY TO IDENTIFY ASYMPTOMATIC COVID-19 POSITIVE INDIVIDUALS. HOWEVER, TESTING DOES NOT GUARANTEE A COVID-FREE UNIT DUE TO THE POTENTIAL FOR FALSE NEGATIVE TEST RESULTS. COMMANDERS SHALL ASSUME COVID IS ON THEIR SHIPS AND SUBMARINES AND ENSURE STRICT COMPLIANCE TO HEALTH PROTECTION MEASURES UNTIL SUFFICIENT COVID-FREE UNDERWAY TIME HAS ELAPSED AND BUBBLE INTEGRITY HAS BEEN MAINTAINED. 3.C.6. USE OPERATIONAL UNIT RETURN TO WORK (RTW) GUIDANCE, PARA. 7.D.1 TO CLEAR COVID POSITIVE INDIVIDUALS. 3.D. SHIP RIDERS (E.G. CONTRACTORS, TECH REPS, INSPECTION TEAMS, ETC.), DIRECT SUPPORT PERSONNEL, AND ALL OTHERS ASSISTING COMMANDS PRIOR TO BUBBLE ESTABLISHMENT WILL ADHERE TO LOCAL FORCE HEALTH PROTECTION REQUIREMENTS (DAILY COVID-19 SCREENING QUESTIONNAIRE, TEMPERATURE CHECKS, SOCIAL DISTANCING, PPE USAGE, RESTRICTED SHIPBOARD MOVEMENT, SANITIZATION, ETC.). WHEN INVOLVED IN MOVEMENT TO SEQUENTIAL COMMANDS, IT MAY BE ADVISABLE TO ROM-SEQUESTER COHORTS, USE B2BT, AND/OR TEST PERIODICALLY. 3.E. [MOD] SHIP RIDERS (E.G. CONTRACTORS, TECH REPS, INSPECTION TEAMS, ETC.), DIRECT SUPPORT PERSONNEL, AND ALL OTHERS (E.G. PCS PERSONNEL) PENETRATING AN ESTABLISHED BUBBLE WILL COMPLETE A 14-DAY ROM-SEQUESTER WITH A NEGATIVE TEST PRIOR TO EMBARKING. A NEGATIVE TEST IS NOT REQUIRED FOR PERSONNEL WHO RECOVERED FROM COVID-19 WITHIN THE PAST 90 DAYS (DUE TO THE POSSIBILITY OF PERSISTENT POSITIVE RESULTS IN NON-INFECTIOUS PERSONS). IMMUNIZED PCS AND SHIP RIDERS WHO ARE ASYMPTOMATIC DO NOT NEED TO CONDUCT ROM PRIOR TO VISITING A 100% IMMUNIZED SHIP, BUT SHOULD HAVE A NEGATIVE TEST WITHIN PAST 72 HOURS BEFORE EMBARKING A PARTIALLY IMMUNIZED SHIP. ALL INDIVIDUALS MUST MAINTAIN HEALTH PROTECTION MEASURES UNTIL MORE IS UNDERSTOOD ABOUT AN IMMUNIZED INDIVIDUALS ABILITY TO TRANSMIT THE DISEASE. USE OPERATIONAL UNIT RTW GUIDANCE TO CLEAR COVID POSITIVE PERSONNEL, PARA. 7.D.1. MITIGATION PLANS TO PENETRATE AN ESTABLISHED BUBBLE WITHOUT A 14 DAY ROM-SEQUESTER AND/OR TEST DUE TO EMERGENT OPERATIONAL REQUIREMENTS MUST BE APPROVED BY THE NCC OR NCC-DESIGNATED APPROVAL AUTHORITIES. 4. MINIMUM REQUIRED ACTION FOR MAINTENANCE, BASIC, ADVANCED/INTEGRATED, AND SUSTAINMENT PHASES. 4.A. MAINTENANCE PHASE. AGGRESSIVE AWARENESS, SELF-MONITORING, TIMELY DIAGNOSIS AND THOROUGH CONTACT TRACING ARE ALL CRITICAL TO COMBATTING COVID-19. COMMANDERS MUST REMAIN ALERT TO SIGNS OF COVID SPREAD BY ASYMPTOMATIC SAILORS. SIGNS MAY BE SAILORS FROM DIFFERENT DEPARTMENTS WITHOUT KNOWN COVID POSITIVE SAILORS SUDDENLY EXHIBITING SYMPTOMS. THE FOLLOWING MINIMUM MEASURES APPLY: 4.A.1. COMPLY WITH LOCAL HPCON REQUIREMENTS, HEALTH PROTECTION MEASURES AND BE AWARE OF LOCAL COMMUNITY TRANSMISSION RATES. EMPHASIZE PERSONAL RESPONSIBILITY (FREQUENT HAND WASHING, CLOTH FACE COVERINGS, SOCIAL DISTANCING, AVOIDING LOCAL AREAS WITH HIGH POPULATION DENSITY, SELF- MONITOR, ETC.) EVEN IN THE ABSENCE OF A KNOWN OUTBREAK OR IN AN ESTABLISHED BUBBLE. REPORT AND ISOLATE PERSONNEL WITH COVID-19 SYMPTOMS. SCREEN ALL INDIVIDUALS DAILY PRIOR TO ENTERING THE WORK CENTER IN ACCORDANCE WITH CDC GUIDANCE, AVAILABLE AT HTTPS://WWW.CDC.GOV/SCREENING/INDEX.HTML. CLEAN AND DISINFECT SPACES DAILY IAW NAVSEA CLEANING GUIDANCE. CONSIDER ADDITIONAL COVID-19 OPERATIONAL RISK MANAGEMENT (ORM) MEASURES FOR MAJOR EVENTS (E.G., SHIPBOARD DRILLS). 4.A.2. [MOD] SUPPORT ORGANIZATION COMMANDERS (E.G. SHIPYARD PERSONNEL, CONTRACT SUPPORT, TRAINING TEAMS) CONSIDER FACTORS SUCH AS THE CURRENT HPCON, CDC THREAT LEVEL, METHOD/MODE OF TRAVEL, IMMUNIZATION STATUS, ETC. WHEN ASSESSING RISK AND DETERMINING WHETHER ROM-SEQUESTER IS WARRANTED. VISITORS SHOULD FOLLOW THE SAME DAILY SCREENING PROCEDURES, SELF-MONITORING, TEMPERATURE CHECKS, SOCIAL DISTANCING, PPE USAGE, AND PERSONAL RESPONSIBILITY PROTOCOLS AS SHIP FORCE. 4.A.3. AIRCRAFT SQUADRON COMMANDERS SHOULD CONSIDER THE CURRENT RISK LEVEL PER PARAGRAPH 4.A.2 TO DETERMINE IF ROM-SEQUESTER IS REQUIRED FOR TRAINING DETACHMENTS. FOR EXAMPLE, A SAILOR MAY USE A PERSONAL VEHICLE TO DRIVE FROM MILITARY BASE TO MILITARY BASE WITH INFREQUENT GAS OR FOOD STOPS TO MAINTAIN A MODIFIED BUBBLE. REGARDLESS, TRAVELERS SHOULD FOLLOW THE SAME DAILY SCREENING PROCEDURES, SELF-MONITORING, TEMPERATURE CHECKS, SOCIAL DISTANCING, PPE, AND PERSONAL RESPONSIBILITY PROTOCOLS DICTATED BY LOCAL HPCON CONDITIONS. 4.A.4. FULLY IMMUNIZED UNITS. FULLY IMMUNIZED UNITS MAY TAKE ADVANTAGE OF THE RELAXATIONS AFFORDED DEPLOYING UNITS IN PARA 3.C.1 THROUGHOUT THE OFRP CYCLE. 4.B. BASIC AND ADVANCED PHASES. INCLUDES SAME MEASURES AS THE MAINTENANCE PHASE, PLUS: 4.B.1. [MOD] UNDERWAY OPERATIONS WITH SHORE BASED MEDICAL TREATMENT FACILITY (MTF) SUPPORT OR AFLOAT MTF (T-AH/CVN/LHA/LHD) WITHIN 72 HOURS: SCREEN HIGH RISK SAILORS AND ENSURE PPE LOADOUT MEETS FLEET GUIDANCE. CONDUCT DAILY SCREENING PROCEDURES FOR COVID-19 SYMPTOMS. FOLLOW PLATFORM SPECIFIC COVID-19 CONOPS AND STANDARD OPERATING PROCEDURES (SOPS). 4.B.2. UNDERWAY OPERATIONS WHEN MTF SUPPORT WILL NOT BE AVAILABLE WITHIN 72 HOURS: SAME MEASURES AS LOCAL OPERATIONS, PLUS, IAW FLEET COMMANDER GUIDANCE, CONSIDER MEDICAL TEAM AUGMENT, MEDEVAC AUGMENT/HELO CAPABILITY, AND/OR SHIPBOARD TESTING CAPABILITY. 4.C. INTEGRATED PHASE: SAME MEASURES AS MAINTENANCE AND BASIC AND ADVANCED PHASES, PLUS: 4.C.1. IF DEPLOYING IMMEDIATELY AFTER INTEGRATED PHASE (E.G., COMPTUEX(C2X), ARGMEUEX) OR PRE-OVERSEAS MOVEMENT EVALUATION (POMEVAL), FOLLOW THE GUIDANCE IN PARAGRAPH 3. 4.D. SUSTAINMENT PHASE. 4.D.1. UNDERWAY: MAINTAIN BUBBLE PER PARAGRAPHS 3.D AND 3.E. 4.D.2. PIER-SIDE: FOLLOWING DEPLOYMENT, FOLLOW BASIC PHASE GUIDANCE. OPERATIONAL COMMANDERS MAY ELECT TO SHIFT TO PARAGRAPH 3 GUIDANCE DEPENDING ON LIKELIHOOD OF CONTINGENCY OPERATIONS. 4.E. [MOD] FOR SHORE BASED COMMANDS SENDING PERSONNEL TO AFLOAT UNITS, FOLLOW THE GUIDANCE THAT APPLIES TO THE PHASE OF THE RECEIVING UNIT. FOR ALL OPERATIONAL UNIT PERSONNEL TRAVELING TO SHORE COMMANDS (E.G., SCHOOLS, TDY), FOLLOW MAINTENANCE PHASE CRITERIA OF PARA 4.A. AND REQUIREMENTS OF REF (C) AS MODIFIED BY REF (L). INDIVIDUALS WHO ARE IMMUNIZED AND CONDUCTING A SHORE BASED TRAINING TRACK WITH MULTIPLE STOPS DO NOT NEED TO ROM BEFORE OR IN BETWEEN STOPS, BUT MUST MAINTAIN HEALTH PROTECTION MEASURES IAW CDC GUIDANCE. 4.F. [MOD] FOR ALL PHASES, DISCIPLINED INDIVIDUAL AND ORGANIZATIONAL PUBLIC HEALTH PROTECTION MEASURES ARE THE BEDROCK OF RISK REDUCTION AND RISK MITIGATION. COVID-19 MITIGATION PROTOCOL, WHERE APPROPRIATE, SHOULD CONSIDER ADDITIONAL SUPPORT FOR HIGH RISK PERSONNEL. COMMANDERS ARE RESPONSIBLE FOR DEVELOPING, MANAGING, OVERSEEING AND IMPLEMENTING PROTOCOLS FOR THEIR UNITS. INDIVIDUALS ARE RESPONSIBLE FOR EXECUTING THOSE PROTOCOLS. TESTING IS THE ONLY METHOD TO DETECT ASYMPTOMATIC TRANSMISSION WITHIN THE NON-IMMUNIZED FORCE. CONSIDER SCREENING TESTS DURING OFRP CYCLE TO IDENTIFY COVID-19 EARLY AND BREAK TRANSMISSION CYCLE WITHIN THE FLEET. ANTIGEN BASED TESTS HAVE PROVEN EFFECTIVE IF EMPLOYED SERIALLY AND WITH RT-PCR BASED TESTS TO CONFIRM POSITIVE RESULTS. 5. DUE TO THE UNIQUE NATURE OF FORWARD DEPLOYED NAVAL FORCES (FDNF) AND THEIR HOST NATION RELATIONSHIP, THE NCC WILL DEFINE OPERATIONAL REQUIREMENTS FOR FDNF UNITS BASED ON PARAGRAPHS 3 AND 4. 6. COMMANDERS MAY NEED TO EXEMPT AIRCREW AND AIRCRAFT MAINTAINERS FROM THIS GUIDANCE TO MEET EMERGENT OPERATIONAL OR NATOPS CURRENCY REQUIREMENTS. MITIGATION PLANS MUST BE APPROVED BY THE NCC. FOR AVIATION UNITS EMBARKED ON SURFACE UNITS, MITIGATION PLANS WILL BE INCLUDED AND APPROVED AS PART OF THE OVERALL SHIP HEALTH PROTECTION PLAN. 7. REQUIRED ACTION WHEN ANY MILITARY, CIVILIAN, OR CONTRACTOR EXHIBITS SIGNS OR SYMPTOMS OF COVID-19 INFECTION. 7.A. [MOD] ISOLATE, MEDICALLY SCREEN AND DESIGNATE AS A PUI OR PROBABLE COVID-19 CASE. RESTRICT CONTACT AND PRESERVE THE CAPABILITY TO CONDUCT MISSION ESSENTIAL OPERATIONS. 7.A.1. IF ISOLATED ABOARD SHIP, USE SMALL BERTHING AREAS (E.G., STATEROOMS, PREFERABLY WITH HEADS) FOR SEPARATION. WHEN ADEQUATE SHIPBOARD ISOLATION CAPACITY IS EXHAUSTED, CONSIDER TRANSFERRING PUIS TO UNITS WITH REMAINING CAPACITY OR ASHORE IAW FLEET COMMANDER GUIDANCE, IF FEASIBLE AND MISSION ALLOWS. 7.A.2. IF ISOLATED ASHORE, PROVIDE NECESSARY MEDICAL TREATMENT UNTIL CLINICALLY IMPROVED. 7.B. [MOD] IDENTIFY, QUARANTINE, AND MEDICALLY SCREEN CLOSE CONTACTS OF COVID-19 CASES. ISOLATE SYMPTOMATIC PUIS AS DEFINED IN PARAGRAPHS 2.A AND 2.B AS SOON AS POSSIBLE. MINIMUM SCREENING SHOULD INCLUDE USE OF CDC COVID-19 QUESTIONNAIRE, CDC FACILITIES COVID-19 SCREENING, AVAILABLE AT HTTPS://WWW.CDC.GOV/SCREENING/PAPER- VERSION.PDF TO ASSESS RISK. TEST ALL CLOSE CONTACTS OF CONFIRMED OR PROBABLE COVID-19 PATIENTS. PEOPLE WHO HAVE PREVIOUSLY TESTED POSITIVE FOR COVID-19 DO NOT NEED TO QUARANTINE OR GET TESTED AGAIN FOR 3 MONTHS (DUE TO VIRAL SHEDDING), BUT MUST CONTINUE PHYSICAL DISTANCING AND CLOTH FACE COVERING USE. IAW CDC GUIDANCE ALL IMMUNIZED PERSONNEL (GREATER THAN TWO WEEKS AFTER FINAL DOSE OF VACCINE) WHO RECEIVED THEIR LAST DOSE WITHIN THE PAST THREE MONTHS AND HAVE REMAINED ASYMPTOMATIC DO NOT NEED TO QUARANTINE IF THEY ARE A CLOSE CONTACT, BUT MUST FOLLOW STRICT HEALTH PROTECTION MEASURES. WHEN ADEQUATE SHIPBOARD QUARANTINE CAPACITY IS EXHAUSTED, CONSIDER TRANSFERRING CLOSE CONTACTS TO UNITS WITH REMAINING CAPACITY OR ASHORE, IF FEASIBLE AND MISSION ALLOWS. IF QUARANTINE SPACE IS LIMITED, PRIORITIZE NON-IMMUNIZED INDIVIDUALS. 7.B.1. [NEW] CLOSE CONTACTS WHO SUBSEQUENTLY TEST POSITIVE WILL BE ISOLATED AND TREATED UNDER COVID-19 CASE PROTOCOLS. CLOSE CONTACTS ATTACHED TO OPERATIONAL UNITS MUST REMAIN IN QUARANTINE FOR 14 DAYS EVEN IF THEY TEST NEGATIVE. SOME INDIVIDUALS MAY TEST NEGATIVE FOR SEVERAL DAYS AFTER EXPOSURE AND IT MAY TAKE UP TO 14 DAYS TO BECOME COVID-19 POSITIVE OR EXHIBIT SYMPTOMS. IAW REF (E), COMMANDERS OF CLOSE CONTACTS ATTACHED TO NON-OPERATIONAL UNITS AND STAFFS HAVE THREE POSSIBLE QUARANTINE DURATIONS BASED ON WORK ENVIRONMENT AND CIRCUMSTANCES OF CLOSE CONTACT: (1) QUARANTINE 14 DAYS (2) QUARANTINE 10 DAYS OR (3) QUARANTINE 7 DAYS WITH A NEGATIVE TEST ON OR AFTER DAY 5 FOLLOWING CLOSE CONTACT EXPOSURE. QUARANTINE DURATIONS LESS THAN 14 DAYS INCREASE THE RISK OF POST QUARANTINE TRANSMISSION OF INFECTIONS. FOLLOWING 7 OR 10 DAY QUARANTINE, INDIVIDUALS SHOULD WATCH FOR SYMPTOMS UNTIL 14 DAYS AFTER EXPOSURE AND IMMEDIATELY SELF-ISOLATE IF THEY DEVELOP SYMPTOMS. 7.B.2. ASYMPTOMATIC INDIVIDUALS QUARANTINED DUE TO CLOSE CONTACT ARE NOT CONSIDERED A PUI, PER PARAGRAPH 2.B. 7.B.3. IF A CLOSE CONTACT BECOMES SYMPTOMATIC - FOLLOW PUI PROTOCOL. 7.B.4. SPECIFIC TO NAVAL SPECIAL WARFARE INITIAL ACCESSIONS TRAINING ONLY, INCLUSIVE OF THE SEAL/SWCC PIPELINES. BOAT TEAMS WHO ARE CLOSE CONTACTS OF A COVID-19 CASE MAY CONTINUE TO EXECUTE TRAINING AS A COHORT, PHYSICALLY DISTANCED FROM OTHER BOAT CREWS IAW A TRAINING CONOPS APPROVED BY NAVSPECWARCOM. 7.C. PROTOCOL FOR PUI. 7.C.1. ISOLATE AND TEST ALL PUIS. 7.C.2. IF TEST RESULT IS POSITIVE - CONTINUE ISOLATION AND FOLLOW PARAGRAPH 7.D. CONDUCT COVID-19 CONTACT TRACING PER PARAGRAPH 10.D. 7.C.3. IF TEST RESULT IS NEGATIVE - CONTINUE TO ISOLATE AND FOLLOW PARAGRAPH 7.D. PROVIDE MEDICAL TREATMENT UNTIL CLINICALLY IMPROVED. IF A KNOWN COVID-19 OUTBREAK IS OCCURRING, CONTINUE TO ISOLATE AND FOLLOW PARAGRAPH 10.D. 7.C.4. IF TEST RESULT IS NEGATIVE AND PUI DOES NOT IMPROVE - CONTINUE TO ISOLATE AND FOLLOW PARAGRAPH 7.D. IF A KNOWN COVID-19 OUTBREAK IS OCCURRING, CONDUCT COVID-19 CONTACT TRACING PER PARAGRAPH 10.D. 7.C.5. IF NO TEST IS PERFORMED - CONTINUE TO ISOLATE. MEDICALLY SCREEN TWICE A DAY AT A MINIMUM AND, IF SYMPTOMS WORSEN, CONSULT MEDICAL ISIC AND FLEET/TYCOM SURGEON REGARDING TRANSFER TO MEDICAL TREATMENT FACILITY. AT SEA, TRANSFER ASHORE IAW FLEET COMMANDERS GUIDANCE. FOLLOW PARAGRAPH 7.D. IF A KNOWN OR SUSPECTED COVID-19 OUTBREAK IS OCCURRING, CONDUCT COVID-19 CONTACT TRACING PER PARAGRAPH 10.D. 7.D. RETURN TO WORK (RTW) GUIDANCE FOR COVID-19 CASES AND PUIS. 7.D.1. OPERATIONAL UNITS. COVID-19 CASES AND PUIS MUST MEET ALL OF THE FOLLOWING CRITERIA TO RTW: (1) AT LEAST 24 HOURS HAVE PASSED SINCE RESOLUTION OF FEVER WITHOUT THE USE OF FEVER REDUCING MEDICATION; (2) PROGRESSIVE IMPROVEMENT IN OTHER COVID-19 SYMPTOMS AS DETERMINED BY A MEDICAL PROVIDER; AND (3) AT LEAST 14 DAYS HAVE ELAPSED SINCE THE SYMPTOMS FIRST APPEARED OR SINCE THE DATE OF THE FIRST POSITIVE RT-PCR TEST IF ASYMPTOMATIC. 7.D.2. ALL OTHER UNITS AND STAFFS. COVID-19 CASES AND PUIS MUST MEET ALL OF THE FOLLOWING CRITERIA TO RTW: (1) AT LEAST 24 HOURS HAVE PASSED SINCE RESOLUTION OF FEVER WITHOUT THE USE OF FEVER REDUCING MEDICATION; (2) IMPROVEMENT IN OTHER COVID-19 SYMPTOMS; AND (3) AT LEAST 10 DAYS HAVE ELAPSED SINCE THE SYMPTOMS FIRST APPEARED OR RT-PCR TEST DATE IF ASYMPTOMATIC. 7.D.3. FOR SEVERE CASES WHERE INDIVIDUALS REQUIRED HOSPITALIZATION, EXTEND THE DURATION OF ISOLATION SUCH THAT RTW IS NO EARLIER THAN DAY 21 (20 DAYS SINCE SYMPTOM ONSET) AS SOME PERSONS WITH SEVERE COVID-19 ILLNESS MAY REMAIN INFECTIOUS FOR SLIGHTLY LONGER PERIODS OF TIME. 7.D.4. RETURN TO PHYSICAL EXERCISE. THE RTW GUIDANCE IN 7.D.1 THROUGH 7.D.3 IS BASED ON RESOLUTION OF INFECTIVITY. BASED ON SEVERITY OF ILLNESS, SOME PERSONNEL MAY REQUIRE TIME TO GRADUALLY RETURN TO INTENSE EXERCISE. REF (H) CONTAINS RETURN TO EXERCISE RECOMMENDATIONS. 7.D.5. NCC MAY ELECT TO TREAT CRITICAL OPERATIONAL ENABLERS, SUCH AS INSPECTION AND CERTIFICATION TEAMS, AS OPERATIONAL UNITS PER PARA. 7.D.1. 7.D.6. A TEST-BASED STRATEGY IS NO LONGER RECOMMENDED TO DETERMINE RTW BECAUSE IN THE MAJORITY OF CASES IT RESULTS IN IDENTIFYING THOSE WHO CONTINUE TO SHED DETECTABLE SARS-COV-2 RNA BUT ARE NO LONGER INFECTIOUS. A COMBINATION OF BOTH SYMPTOM RESOLUTION AND TESTING CRITERIA IS NOT RECOMMENDED AS IT WILL LIKELY EXTEND RTW WITH NO CORRESPONDING DECREASE OF INFECTION TRANSMISSION. 7.D.7. COVID LIKE ILLNESS (CLI)/INFLUENZA LIKE ILLNESS (ILI). INDIVIDUALS WITH ILI OR CLI SHOULD BE EVALUATED BY A PROVIDER AND IN THE CONTEXT OF IMMUNIZATION SHOULD BE DIRECTED TO THE APPROPRIATE ISOLATION, QUARANTINE, OR SICK-IN-QUARTERS RECOMMENDATION. 7.D.7.A. A PATIENT WITH SUSPECTED CLI/ILI WHO HAS TESTED NEGATIVE FOR COVID-19 MAY RETURN TO WORK AFTER THE FOLLOWING CRITERIA HAVE BEEN MET: (1) AT LEAST 24 HOURS AFTER THE RESOLUTION OF FEVER WITHOUT THE USE OF FEVER REDUCING MEDICATION; (2) IMPROVEMENT IN SYMPTOMS AND (3) AT LEAST 10 DAYS SINCE THE ONSET OF SYMPTOMS. 7.D.7.B. THE SYMPTOMS OF ILI (THE FLU) ARE SIMILAR TO CLI SYMPTOMS, AND THE ABSENCE OF COVID-SPECIFIC SYMPTOMS, OR TESTING POSITIVE FOR ANOTHER ILLNESS SUCH AS INFLUENZA, DOES NOT ELIMINATE THE POSSIBILITY F COVID INFECTION. THE RISK OF COVID AND ILI CO-INFECTION EXISTS AND THE CDC RECOMMENDS EXECUTING THE FULL COVID ISOLATION PERIOD FOR ALL SYMPTOMATIC INDIVIDUALS, EVEN WHEN TESTING NEGATIVE FOR COVID-19. THEREFORE, RETURN TO WORK CRITERIA FOR ILI AND CLI ARE THE SAME. A NCC WITH MEDICAL CONCURRENCE MAY, WHEN REQUIRED BY OPERATIONAL DEMANDS, REDUCE THE RETURN TO WORK DURATION OF SUSPECTED FLU WITH A NEGATIVE COVID TEST TO 24 HOURS AFTER RESOLUTION OF FEVER WITHOUT THE USE OF FEVER REDUCING MEDICATION, IMPROVEMENT IN SYMPTOMS AND 7 DAYS (VICE 10) SINCE ONSET OF SYMPTOMS. A NCC WITH MEDICAL CONCURRENCE MAY RETURN AN IMMUNIZED INDIVIDUAL TO WORK WITH A NEGATIVE COVID TEST. THESE ARE NCC RISK DECISIONS THAT SHOULD BE MADE ONLY UNDER OPERATIONAL NECESSITY. 7.E. COVID-19 CASES MAY CONTINUE TO TEST POSITIVE FOR UP TO THREE MONTHS DUE TO THE PRESENCE OF PERSISTENT NON-INFECTIOUS VIRAL FRAGMENTS. THEREFORE, COVID-19 CASES ARE EXEMPT FROM ANY REQUIRED TESTING PROTOCOL FOR THREE MONTHS FOLLOWING ANY POSITIVE TEST. INDIVIDUALS THAT EXHIBIT NEW OR PERSISTENT SYMPTOMS DURING THAT THREE MONTH PERIOD SHOULD BE EVALUATED BY A MEDICAL PROVIDER. STUDIES HAVE NOT FOUND EVIDENCE THAT CLINICALLY RECOVERED PERSONS WITH PERSISTENCE OF VIRAL RNA HAVE TRANSMITTED COVID-19 TO OTHERS. 7.E.1. RECOVERED PERSONS MUST CONTINUE TO WEAR CLOTH FACE COVERINGS AND SOCIAL DISTANCE INFECTION PRECAUTIONS MUST CONTINUE TO BE TAKEN AFTER RTW IS APPROVED. 7.F. ANTIBODY TESTING AND VIRAL CULTURE. ANTIBODY TESTING OR VIRAL CULTURE SHOULD NOT BE USED AS A PRIMARY OR STAND-ALONE RETURN TO WORK CRITERION. HOWEVER, IF EITHER HAVE BEEN OBTAINED DURING A COVID CASE CLINICAL EVALUATION, RESULTS MAY BE USED AS SUPPLEMENTAL CRITERIA FOR PARTICULARLY CHALLENGING CASES OR FOR PUBLIC HEALTH OUTBREAK MANAGEMENT PURPOSES. 7.G. COMMAND AND MEMBER NOTIFICATION. THE INDIVIDUAL SICK SLIP (DD FORM 689) MUST BE USED TO NOTIFY BOTH THE MEMBER AND THE CHAIN OF COMMAND OF ANY TEST-CONFIRMED OR PRESUMPTIVE COVID ILLNESS, WHETHER SYMPTOMATIC OR NOT. SECTION 11 (DISPOSITION) AND SECTION 12 (REMARKS) MUST CLEARLY INDICATE THE MEDICALLY-RECOMMENDED DISPOSITION, FOLLOW UP, AND QUARANTINE/ISOLATION REQUIREMENTS IN ACCORDANCE WITH THIS GUIDANCE. THE SICK SLIP MUST ALSO BE USED TO NOTIFY ASYMPTOMATIC MEMBERS AND THE CHAIN OF COMMAND OF ANY PUI OR CLOSE CONTACT, QUARANTINE, OR ISOLATION REQUIREMENTS IN ACCORDANCE WITH THIS GUIDANCE. BEGINNING AND ENDING DATES OF THE QUARANTINE/ISOLATION PERIOD, SYMPTOM-FREE REQUIREMENTS, AND MEDICAL FOLLOW UP MUST BE CLEARLY INDICATED IN SECTION 12 (REMARKS). 8. UNDERWAY TESTING. 8.A. [MOD] UNDERWAY OPERATIONS SHOULD CONTINUOUSLY ASSESS THE INTEGRITY OF A BUBBLE THROUGH CLI/ILI SCREENING OF NON-IMMUNIZED PERSONNEL. FOR PLATFORMS WITH EXPANDED TESTING CAPABILITY, TESTING STRATEGIES MAY BE EMPLOYED AS PART OF THE HEALTH PROTECTION MEASURES IN 1.C.1 THROUGH 10, TO INCLUDE SYMPTOMATIC TESTING (DIAGNOSTIC) FOR EVERYONE AND TARGETED CREW TESTING (SCREENING) FOR NON-IMMUNIZED SAILORS. 8.B. [MOD] OPERATIONS, ACTIVITIES, AND ENGAGEMENTS DURING DEPLOYMENT MAY NOT ALLOW FOR PERSONNEL TO COMPLETE A 14-DAY ROM/SEQUESTRATION PRIOR TO EMBARKING/RE-EMBARKING A SHIP. COVID-19 SCREENING TESTING OF NON-IMMUNIZED OPERATIONALLY AT-RISK PERSONNEL AND MISSION CRITICAL POPULATIONS MAY DETECT COVID-19 INFECTIONS EARLY AND PRESERVE MISSION EFFECTIVENESS. 8.B.1. [MOD] OPERATIONALLY AT-RISK PERSONNEL, SUCH AS AIR CREW AND INDIVIDUALS ASHORE IN A COUNTRY WITH ACTIVE COVID-19 INFECTIONS, ARE AT THE GREATEST RISK OF EXPOSURE TO THE VIRUS. IF NOT IMMUNIZED, QUARANTINE THESE GROUPS FROM THE REMAINING CREW WHEN RE-ENTERING THE BUBBLE, INCREASE MEDICAL SCREENING AND SELF-MONITORING EFFORTS AND WHEN AVAILABLE, TEST THESE INDIVIDUALS INTO AND OUT OF THE 14-DAY QUARANTINE, EFFECTIVELY CONDUCTING ROM-SEQUESTER AND SCREENING TESTING ONBOARD FOR NON-IMMUNIZED SAILORS. 8.B.2. [MOD] COVID-19 INFECTION IN PERSONNEL WHO ARE CONSIDERED MISSION CRITICAL, SUCH AS CRITICAL CARETAKER CREW, AIR OPERATIONS CREW, AND REACTOR PERSONNEL, MAY DEGRADE OPERATIONS AND IMPACT THE MISSION. PRIORITIZE IMMUNIZATION FOR THESE INDIVIDUALS. WHEN THERE IS A RISK OF INFECTION ONBOARD, PRIORITIZE MISSION CRITICAL NON- IMMUNIZED CREW MEMBERS IN AN AFLOAT TESTING STRATEGY. 8.B.3. [MOD] WIDESPREAD IMMUNIZATION IS THE ONLY SUBSTITUTE FOR AN EFFECTIVE TEST-ROM SEQUESTER-TEST STRATEGY PROCESS TO ESTABLISH AND MAINTAIN THE BUBBLE. DURING UNDERWAY OPERATIONS, BRIEF STOPS FOR PERSONNEL (BSP) OR EMBARKING PERSONNEL FROM FOREIGN PORTS MAY PRECLUDE THE ABILITY TO COMPLETE A 14-DAY ROM-SEQUESTER. IF NOT IMMUNIZED, QUARANTINE THESE PERSONNEL FROM THE REMAINING CREW MEMBERS FOR AT LEAST 14 DAYS, INCREASE MEDICAL SCREENING AND SELF-MONITORING EFFORTS, AND, WHEN AVAILABLE, TEST THESE INDIVIDUALS INTO AND OUT OF THE 14-DAY QUARANTINE. IAW CDC GUIDANCE ALL IMMUNIZED PERSONNEL (GREATER THAN TWO WEEKS AFTER FINAL DOSE OF VACCINE) WHO RECEIVED THEIR LAST DOSE WITHIN THE PAST THREE MONTHS AND HAVE REMAINED ASYMPTOMATIC DO NOT NEED TO QUARANTINE IF THEY ARE A CLOSE CONTACT, BUT MUST FOLLOW STRICT HEALTH PROTECTION MEASURES. 8.C. POOLED TESTING UNDERWAY. POOLED TESTING UNDERWAY WILL ONLY BE CONDUCTED IN DIRECT COORDINATION WITH NAVAL HEALTH RESEARCH CENTER AND REQUIRES NOTIFICATION OF BUMED SURGEON GENERAL OR DEPUTY SURGEON GENERALS OFFICE BY THE FLEET SURGEON. 8.D. [MOD] FLU AND COVID-19 VACCINE. 8.D.1. [MOD] RECEIVING ANY VACCINE MAY CAUSE SOME SYMPTOMS SIMILAR TO COVID-19. 8.D.1.A. [MOD] POSSIBLE FLU OR COVID-19 VACCINE SYMPTOMS MAY INCLUDE MYALGIA, MILD FEVER, CHILLS AND INJECTION SITE SORENESS. 8.D.1.B. [MOD] IF INDIVIDUAL RECEIVES THE FLU OR COVID-19 VACCINE AND EXPERIENCES SYMPTOMS BEYOND 72 HOURS OR SYMPTOMS NOT CONSISTENT WITH THE FLU VACCINE (SUCH AS LOSS OF TASTE OR SMELL, SORE THROAT, CHEST PAIN, TEMPERATURE GREATER THAN 101, OR COUGH), THEY SHOULD BE EVALUATED BY A HEALTHCARE PROVIDER. MAXIMAL PROTECTION IS ONLY PROVIDED APPROXIMATELY 14 DAYS AFTER COMPLETION OF THE SERIES. IT IS STILL POSSIBLE TO CONTRACT THE VIRUS AFTER THE FIRST OR SECOND DOSE OF COVID-19 VACCINE. 8.D.1.C. [NEW] CO-INFECTION WITH COVID-19 AND INFLUENZA IS OCCURRING. UNLIKE THE COVID-19 VACCINE, THE INFLUENZA VACCINE IS A READINESS REQUIREMENT. EFFORTS MUST BE MADE TO ENSURE THAT ALL INDIVIDUALS RECEIVE THE INFLUENZA VACCINATION. 9. POST-DEPLOYMENT AND REDEPLOYMENT. 9.A. [MOD] MILITARY MEMBERS RETURNING TO CONUS FROM DEPLOYMENT WILL COMPLETE A 14-DAY ROM AT HOME STATION. MEMBERS RETURNING VIA SHIP OR MILAIR WITH NO ACTIVE COVID-19 CASES WITHIN THEIR UNIT IN THE LAST 14 DAYS, MAY COUNT TRANSIT TIME (BEGINNING ON THE DAY OF DEPARTURE FROM THE LAST PORT OR AIRFIELD) TOWARD THE ROM REQUIREMENT. SERVICE MEMBERS ON POST-DEPLOYMENT ROM ARE RESTRICTED TO THEIR PERSONAL RESIDENCE OR OTHER APPROPRIATE DOMICILE AND MUST LIMIT CLOSE CONTACTS. IMMUNIZED INDIVIDUALS HAVE NO POST-DEPLOYMENT ROM REQUIREMENTS BUT MUST LIMIT CLOSE INTERACTIONS AND FOLLOW STRICT HEALTH PROTECTION MEASURES IAW CDC GUIDANCE. 9.B. REDEPLOYING INDIVIDUALS MUST BE SCREENED AT THE ASSIGNED PLACE OF DUTY OR POINT OF EMBARKATION. AT A MINIMUM, SCREENING WILL CONSIST OF COVID-19 QUESTIONNAIRE, ASSESSMENT OF EXPOSURE HISTORY, TEMPERATURE CHECK, CHECK FOR COVID-19 SIGNS AND SYMPTOMS LISTED IN PARAGRAPH 2.E., AND REVIEW OF ANY PAST COVID-19 TESTING. 9.C. AT THE COMPLETION OF DEPLOYMENT, ALL PERSONNEL WILL COMPLETE A POST-DEPLOYMENT HEALTH ASSESSMENT (DD FORM 2796) AND POST-DEPLOYMENT HEALTH REASSESSMENT (DD FORM 2900) IN ACCORDANCE WITH REF (F). 9.D. ALL COVID-19 DIAGNOSTIC TESTS AND VACCINATIONS MUST BE ENTERED IN THE MEDICAL RECORD. SCREENING AND SURVEILLANCE TESTS THAT ARE INDIVIDUALLY IDENTIFIABLE MUST BE ENTERED INTO THE MEDICAL RECORD. 10. OUTBREAK INVESTIGATION AND CONTACT TRACING WORKFORCE TRAINING. 10.A. RAPID AND THOROUGH CONTACT TRACING MINIMIZES OUTBREAKS AND IS CRITICAL TO MISSION SUCCESS. BELOW IS A TOOLKIT TO ASSIST WITH THE INVESTIGATION OF CASES OR AN OUTBREAK OF COVID-19 AND CONTAINS LINKS TO CONTACT TRACING TRAINING. THIS INFORMATION CAN BE USED BY MEDICAL AND NON-MEDICAL PERSONNEL TO WORK TOGETHER TO STOP THE SPREAD OF COVID-19. 10.B. ALL UNITS WILL TRAIN A MINIMUM OF TWO PERSONNEL FOR EVERY 100 PERSONNEL AT THEIR COMMAND. COMMANDS OF MORE THAN 500 PERSONNEL MUST TRAIN AT LEAST 10 PEOPLE. SMALL UNITS MUST TRAIN A MINIMUM OF TWO INDIVIDUALS. MSC TRAIN CONTACT TRACERS FOR MSC VESSELS IN ACCORDANCE WITH EXISTING MSC INSTRUCTIONS AND CONTRACTS. 10.C. THE FOLLOWING COMPRISES THE CONTACT TRACING TRAINING: 10.C.1. NAVY VIDEO ON CONTACT TRACING AT: HTTPS://WWW.MILSUITE.MIL AND SEARCH FOR VIDEO 29421. 10.C.2. JOINT KNOWLEDGE ONLINE (JKO) COURSE HIPAA AND PRIVACY ACT TRAINING COURSE NUMBER DHA-US001 HIPAA AND PRIVACY ACT TRAINING ON JKO AT HTTPS://JKO.JTEN.MIL/ (1.5 HOURS). THE HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA) WAS INSTITUTED TO PROTECT THE PRIVACY AND SECURITY OF CERTAIN HEALTH INFORMATION. 10.C.3. [NEW] ONLINE COVID-19 CONTACT TRACING IS AVAILABLE THROUGH NAVY E-LEARNING. COURSE IS TITLED CONTACT TRACING FOR SAILORS AND MARINES [CFHP-NMFSC-CTSM-01]. 10.C.4. IF UNDERWAY OR DO NOT HAVE INTERNET BANDWIDTH TO COMPLETE ONLINE TRAINING, A POWERPOINT VERSION OF CONTACT TRACING TRAINING CAN BE ACCESSED AT: HTTPS://ESPORTAL.MED.NAVY.MIL/SITES/NMCPHC/PPS/WPPC19/ COVID-19_CONTACT_TRACING_TRAINING.ASPX. 10.C.5. AFTER FINISHING THE TRAINING, THE TRAINED MEMBER WILL CONTACT THE PUBLIC HEALTH OFFICER AT THE NEAREST NAVY MEDICINE READINESS AND TRAINING COMMAND (NAVMEDREADTRNCMD), OR THE COMMAND LOCAL MEDICAL PERSONNEL IF ASSOCIATED WITH A NAVMEDREADTRNCMD/OPERATIONAL UNIT, TO IDENTIFY A MENTOR FOR QUESTIONS, GUIDE ACTIVITIES RELATED TO CONTACT TRACING, AND ENSURE COMPLIANCE WITH RELEVANT MEDICAL AUTHORITY (E.G., COMUSFLTFORCOM SURGEON, COMPACFLT SURGEON, OR COMNAVSPECWARCOM SURGEON) GUIDANCE AND PROCEDURES WITH RESPECT TO CONTACT TRACING. THE RELEVANT MEDICAL AUTHORITY AND FACILITY MAY HAVE SPECIFIC FORMS OR PROCEDURES THAT ARE UNIQUE TO THEIR ENVIRONMENT. IT IS IMPORTANT THAT CONTACT TRACING BE A COORDINATED EFFORT BETWEEN THE TRAINED MEMBER AND THE LOCAL NAVMEDREADTRNCMD PUBLIC HEALTH OFFICE WHEN IN GARRISON OR THE COGNIZANT TYCOM FOR OPERATIONAL UNITS. ADDITIONALLY, TIMELY ENGAGEMENT OF THE ASSOCIATED NAVY AND ENVIRONMENTAL AND PREVENTIVE MEDICINE UNIT (NEPMU) IS RECOMMENDED FOR AN EFFECTIVE RESPONSE TO A LARGE OUTBREAK. 10.D. THE FOLLOWING IS THE COVID-19 CASE INVESTIGATION CHECKLIST (APPLIES TO ALL CLINICALLY SUSPECTED OR CONFIRMED CASES). 10.D.1. IMMEDIATE STEPS: (1) IMPLEMENT APPROPRIATE CONTROL MEASURES. (2) SEPARATE THE CASE FROM OTHER PERSONNEL. (3) PLACE THE CASE IN ISOLATION (AS SOON AS POSSIBLE). (4) FOR SHIPS THAT ARE PIER-SIDE, ONCE MEDICAL EVALUATION AND DISPOSITION HAS OCCURRED, ISOLATE CASES OFF OF THE SHIP WHENEVER POSSIBLE. (5) FOR SHIPS THAT ARE UNDERWAY, ISOLATE CASES IN DESIGNATED SPACES, CONSISTENT WITH TYCOM/FLEET/COMMAND DIRECTION AND FLEET COMMANDER PUBLISHED COVID UNDERWAY GUIDANCE SOP. 10.D.2. WEAR APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT (PPE) AS DIRECTED BY YOUR LOCAL MEDICAL AUTHORITY DURING ALL FACE-TO-FACE INTERACTION WITH THE CASE. COVID-19 SPECIFIC PPE INCLUDES (WHEN AVAILABLE) GOWN, GLOVES, NIOSH-CERTIFIED DISPOSABLE N95 RESPIRATOR, AND EYE PROTECTION. CFCS CAN BE USED IF MAINTAINING APPROPRIATE SOCIAL DISTANCING RECOMMENDATIONS. 10.D.3. NOTIFY CHAIN OF COMMAND. 10.D.4. NOTIFY SENIOR MEDICAL DEPARTMENT REPRESENTATIVE, DEPARTMENT OF DEFENSE (DOD) PREVENTIVE MEDICINE AUTHORITY, AND LOCAL CIVILIAN HEALTH DEPARTMENT (IF APPLICABLE) OF ANY CONFIRMED COVID-19 CASE. 10.D.5. IF THE CASE(S) HAS BEEN ONBOARD THE SHIP DURING THE INFECTIOUS PERIOD (48 HOURS BEFORE SYMPTOM ONSET OR POSITIVE LAB UP TO THE TIME OF ISOLATION), ALL AREAS VISITED (WORKSPACE, HEADS, BERTHING, GYMS, ETC.) SHOULD BE CLOSED OFF IN ORDER TO MINIMIZE POTENTIAL EXPOSURE TO AEROSOLIZED VIRUS. WAIT 24 HOURS (OR AS LONG AS PRACTICAL) FROM THE TIME THE CASE WAS LAST PRESENT IN SPACES BEFORE REENTERING THOSE AREAS TO CLEAN AND DISINFECT. 10.D.6. BEGIN A CASE INVESTIGATION AS SOON AS A PERSON PRESENTS WITH COVID-19 LIKE ILLNESS (PUI). INTERVIEW THE CASE(S) OR PUI(S) AND REVIEW MEDICAL RECORDS (IF APPLICABLE) TO ASSESS VALIDITY OF THE DIAGNOSIS AND DETERMINE FOLLOW-UP RESPONSE MEASURES. (1) IF DETERMINED NOT TO BE VALID, RESPONSE STOPS. CLOSED-OFF AREAS MAY BE RE-OPENED. (2) IF DETERMINED TO BE A VALID CLINICALLY-SUSPECTED OR CONFIRMED CASE, PROCEED. 10.D.7. CONDUCT A DETAILED CASE INTERVIEW. AS SOON AS POSSIBLE (IDEALLY WHEN CASE PRESENTS TO MEDICAL OR WITHIN 24 HOURS), COMPLETE THE CASE INTERVIEW AND CONTACT TRACING FORM AND CONTACT LIST FOR EACH CASE. KEY ASPECTS OF THE CASE INTERVIEW INCLUDE: (1) ANY KNOWN HIGH-RISK EXPOSURE THAT THE CASE HAD (E.G., TRAVEL, CONTACT WITH A CONFIRMED COVID-19 CASE), AND TIMELINE OF EXPOSURE. (2) SYMPTOM HISTORY (INCLUDING EXACT DATE OF ONSET OF ANY SYMPTOMS AND LIST OF SYMPTOMS). (3) LIST OF ALL POSSIBLE CLOSE CONTACTS (PER DEFINITION ABOVE) WHO WERE EXPOSED TO THE CASE BETWEEN 48 HOURS PRIOR TO ONSET OF SYMPTOMS AND THE TIME HE/SHE WAS ISOLATED, OR 48 HOURS PRIOR TO A POSITIVE TEST IF THE CASE IS ASYMPTOMATIC. CONTACTS OF CONTACTS ARE NOT CONSIDERED EXPOSED TO COVID-19. THERE IS NO REQUIREMENT TO MONITOR OR QUARANTINE CONTACTS OF CONTACTS, UNLESS THE INITIAL CONTACT LATER DEVELOPS SYMPTOMS AND BECOMES A CASE. (4) DATE OF ISOLATION. ENSURE NO CONTINUED EXPOSURES ARE OCCURRING, ESPECIALLY WITH HOUSEHOLD CONTACTS. 10.D.8. [MOD] QUARANTINE ALL CLOSE CONTACTS AS SOON AS POSSIBLE AFTER EXPOSURE TO THE CASE HAS BEEN VERIFIED. PEOPLE WHO HAVE PREVIOUSLY TESTED POSITIVE FOR COVID-19 DO NOT NEED TO QUARANTINE FOR UP TO 3 MONTHS AS LONG AS THEY DO NOT DEVELOP SYMPTOMS AGAIN. IAW CDC GUIDANCE ALL IMMUNIZED PERSONNEL (GREATER THAN TWO WEEKS AFTER FINAL DOSE OF VACCINE) WHO RECEIVED THEIR LAST DOSE WITHIN THE PAST THREE MONTHS AND HAVE REMAINED ASYMPTOMATIC DO NOT NEED TO QUARANTINE IF THEY ARE A CLOSE CONTACT, BUT MUST FOLLOW STRICT HEALTH PROTECTION MEASURES. 10.D.9. IF INDICATED, COLLECT AND SHIP LABORATORY SPECIMENS TO THE APPROPRIATE DOD, COMMERCIAL, OR PUBLIC HEALTH LABORATORY CERTIFIED TO PERFORM COVID-19 TESTING (CHOSEN LAB AND SHIPPING PROCEDURES WILL BE DETERMINED BY LOCAL PROTOCOLS). DOCUMENT TEST RESULTS FOR ANY OTHER RESPIRATORY PATHOGENS (E.G. RAPID FLU, RESPIRATORY PANEL). (1) FOR SHORE-BASED UNITS OR SHIPS THAT ARE PIER-SIDE IN HOMEPORT, FOLLOW SUPPORTING MILITARY TREATMENT FACILITY (MTF) OR LOCAL CIVILIAN PROCEDURES FOR COVID-19 TESTING. (2) FOR SHIPS THAT ARE UNDERWAY, SHIP CAPABILITIES AND FLEET POLICIES WILL DETERMINE TESTING PRACTICES. EVERY EFFORT SHOULD BE MADE TO TEST AND CONFIRM THE PATHOGEN IF AN OUTBREAK IS SUSPECTED. 11. ADDITIONAL ROM AND MEDICAL SCREENING CONSIDERATIONS. 11.A. CIVILIAN EMPLOYEES. COMMANDERS MUST ENSURE ROM AND MEDICAL SCREENING GUIDANCE GIVEN TO DOD CIVILIAN EMPLOYEES CAN BE APPLIED CONSISTENT WITH APPLICABLE CIVILIAN PERSONNEL LAW, REGULATION, AND POLICY. COMMANDERS SHOULD CONSIDER TELEWORK, OR AS A LAST RESORT, WEATHER AND SAFETY LEAVE AS OPTIONS TO FACILITATE DOD CIVILIAN COMPLETION OF ROM. COMMANDERS ARE ENCOURAGED TO CONSULT THEIR SERVICING OGC COUNSEL, STAFF JUDGE ADVOCATES, AND/OR HUMAN RESOURCE OFFICE FOR CASE-SPECIFIC GUIDANCE. 11.B. CONTRACTOR PERSONNEL. THIS GUIDANCE DOES NOT ALTER, MODIFY, OR CHANGE THE TERMS AND CONDITIONS OF ANY DOD CONTRACT. COMMANDERS MUST ENSURE ROM AND MEDICAL SCREENING GUIDANCE GIVEN TO DOD CONTRACTOR PERSONNEL CAN BE APPLIED CONSISTENT WITH THE PERTINENT CONTRACT AND APPLICABLE PROCUREMENT LAW, REGULATION, AND POLICY. COMMANDERS ARE ENCOURAGED TO CONSULT THEIR SERVICING OGC COUNSEL, STAFF JUDGE ADVOCATES, AND/OR CONTRACTING PERSONNEL FOR CASE-SPECIFIC GUIDANCE. ONLY WARRANTED CONTRACTING OFFICERS CAN ALTER TERMS AND CONDITIONS OF A DOD CONTRACT, INCLUDING PROVISIONS FOR PAYMENT OF COSTS ASSOCIATED WITH DOD CONTRACTOR ROM. 12. [NEW] COVID-19 VACCINATION AND IMMUNIZATION. 12.A. [NEW] WIDESPREAD IMMUNIZATION. ALTHOUGH COVID-19 VACCINES ARE AVAILABLE AND BEING WIDELY ADMINISTERED THROUGHOUT THE NAVY IAW THE DOD PRIORITIZATION SCHEMA, IT WILL TAKE TIME TO ACHIEVE WIDESPREAD FORCE AND NATION IMMUNIZATION. SOME COVID VACCINES DEMONSTRATED A HIGH LEVEL OF EFFICACY (95%) DURING CLINICAL TRIALS AND REDUCE INDIVIDUAL RISK FROM THE DISEASE AND HOSPITALIZATION RELATED TO COVID INFECTION. THEY HAVE MET RIGOROUS SAFETY CRITERIA AND INDIVIDUALS ARE HIGHLY ENCOURAGED TO GET THE VACCINE TO PROTECT THEMSELVES, THEIR SHIPMATES AND THEIR FAMILY. AN INDIVIDUAL DOES NOT ACHIEVE IMMUNITY IMMEDIATELY AND RESEARCH IS ONGOING TO UNDERSTAND WHEN PEAK IMMUNITY OCCURS AND HOW LONG IT LASTS. THE CDC WEB SITE IS THE BEST SOURCE OF CURRENT INFORMATION REGARDING VACCINES. 12.B. [NEW] SAFE HAVEN PORTS. NCCS MAY ALLOW IMMUNIZED INDIVIDUALS ON UNITS MAKING PORT CALLS IN OVERSEAS SAFE HAVEN PORTS WHERE THERE IS U.S. PRESENCE AND BASE FACILITIES (E.G. GUAM, BAHRAIN, YOKOSUKA, ROTA, SASEBO, ETC.) TO TAKE ADVANTAGE OF BASE SERVICES. COMMANDERS SHOULD TAKE INTO ACCOUNT A PORTS PREVALENCE OF COVID-19 AND UTILIZE BEST AVAILABLE MEDICAL DATA WHEN DETERMINING HEALTH PROTECTION STRATEGY FOR THOSE WHO ARE NOT IMMUNIZED. 12.C. [NEW] SECOND DOSE VACCINATION TIMING. CURRENT COVID-19 VACCINATIONS ARE TWO DOSE SERIES. THE SECOND DOSE SHOULD BE ADMINISTERED AS CLOSE TO THE EUA RECOMMENDED INTERVAL AS POSSIBLE (DAY 21 FOR PFIZER AND DAY 28 FOR MODERNA). TO SUPPORT PLANNING FLEXIBILITY THE SECOND DOSE MAY BE ADMINISTERED WITHIN 4 DAYS PRIOR AND 7 DAYS AFTER THE RECOMMENDED INTERVAL. IF IT IS NOT FEASIBLE TO ADHERE TO THE RECOMMENDED INTERVAL DUE TO EXTENUATING CIRCUMSTANCES, THE SECOND DOSE MAY BE ADMINISTERED UP TO 42 DAYS AFTER THE FIRST DOSE. WHEN ADMINISTERING TO BOTH FIRST DOSE AND SECOND DOSE RECIPIENTS ON THE SAME DAY, COMPLETING THE SECOND DOSE SHOULD IDEALLY TAKE PRIORITY OVER ADMINISTERING FIRST DOSE BASED ON VACCINE AVAILABILITY. COMMANDERS MUST ENSURE SECOND DOSE TIMING IS PLANNED AND OPERATIONAL COMMITMENTS SUPPORT INITIATING THE VACCINE SEQUENCE. INDIVIDUALS SHOULD PLAN TO RECEIVE THE VACCINE SEQUENCE AT THE SAME MTF TO EASE LOGISTICS. 12.D. [NEW] READINESS VACCINATION PRIORITY. CURRENTLY, COVID-19 IMMUNIZATION IS NOT A READINESS REQUIREMENT AND UNTIL THESE VACCINES ARE LICENSED OR THE PRESIDENT MANDATES, RECEIPT OF THE COVID-19 VACCINE WILL NOT BE CONSIDERED A READINESS REQUIREMENT. IN THIS CONTEXT, VACCINES THAT ARE REQUIRED FOR READINESS (E.G., FLU VACCINE) ARE CONSIDERED PRIORITY FOR INDIVIDUAL VACCINATIONS. IN CONSIDERING TIMING OF COVID-19 VACCINATIONS AND READINESS REQUIRED VACCINES, THE READINESS VACCINE WILL TAKE PRIORITY. 12.E. [NEW] CONTRACTOR VACCINATION. CONTRACTORS WHO ARE NOT NORMALLY OFFERED INFLUENZA VACCINES THROUGH A LOCAL MTF, BUT WHO ARE IDENTIFIED BY THEIR COMMANDERS AS PROVIDING CRITICAL MISSION ESSENTIAL FUNCTIONS ON DOD INSTALLATIONS OR IN AN OPERATIONAL ENVIRONMENT, AND WHO ARE APPROVED BY THE FIRST FLAG OR SES IN THEIR CHAIN OF COMMAND MAY BE OFFERED VACCINATION. 12.F. [NEW] OTHER REQUIREMENTS. VACCINE ADMINISTRATION, REPORTING, AND GOALS ARE OUTLINED IN REF (R). 13. [NEW] TESTING AND REPORTING REQUIREMENTS. 13.A. [NEW] THE DOD COVID-19 TASK FORCE DIAGNOSTICS AND TESTING LINE OF EFFORT (CVTF-D&T) IS RESPONSIBLE FOR MAINTAINING THE COVID-19 LABORATORY TESTING COMMON OPERATING PICTURE (COP) TO ENSURE CLINICAL TESTING CAPABILITIES AND MITIGATE RISK TO MISSION. CVTF-D&T PROVIDES ASSISTANCE TO THE SERVICES AND COMBATANT COMMANDS IN PRIORITIZATION AND ALLOCATION OF LIMITED COVID-19 TESTING INSTRUMENTS, TEST KITS, AND ASSOCIATED TESTING SUPPLIES AS PER REF (N). 13.B. [NEW] THE OPNAV COVID-19 CRISIS ACTION TEAM (CAT) CONSOLIDATES SERVICE TESTING REQUIREMENTS FOR ALL NON-DIAGNOSTIC TESTING WITHIN THE US NAVY AND REPORTS TO THE CVTF-D&T ON A WEEKLY BASIS. ECHELON 2 AND ECHELON 3 COMMANDERS CONSOLIDATE SUBMITTED REQUESTS FOR ALL SUBORDINATE TESTING AND REPORTED COMPLETION OF PREVIOUSLY REQUESTED TESTING REQUIREMENTS TO THE OPNAV COVID-19 CAT NO LATER THAN 1400R EACH THURSDAY. REPORTING IS REQUIRED FOR ALL NON-DIAGNOSTIC TESTING, TO INCLUDE TESTING PERFORMED ABOARD SHIP USING DEPLOYED EQUIPMENT. 13.C. [NEW] UNITS SHALL MAINTAIN AND SUBMIT A ROLLING, 60-DAY FORECAST FOR ASYMPTOMATIC TESTING. ANY UNIT REQUESTING UNPLANNED TESTING WITHIN THREE WEEKS OF THE EXECUTION DATE REQUIRES FIRST FLAG APPROVAL. UNITS SHOULD COORDINATE SPECIFIC DETAILS OF TESTING EVOLUTIONS DIRECTLY WITH THE TESTING FACILITY ASSIGNED BY THE CVTF-D&T. DUE TO THE DYNAMIC NATURE OF THIS PUBLIC HEALTH CRISIS, ASSIGNED TESTING FACILITIES MAY NOT ALWAYS BE ABLE TO ACCOMMODATE REQUESTS, SO ANY UNIT WHO BECOMES AWARE OF A CONFLICT SHOULD REPORT THE DISCREPANCY TO THE OPNAV COVID-19 CAT WHO WILL WORK WITH THE CVTF-D&T TO ASSIGN AN ALTERNATE TESTING LOCATION. 13.D. [NEW] DUE TO AVAILABILITY LIMITATIONS FOR BIOFIRE TEST PANELS, ALL DOD COMPONENT REQUESTS TO PURCHASE BIOFIRE TEST PANELS, INCLUDING THOSE WITH EXISTING CONTRACTS WITH BIOFIRE, WILL SUBMIT NEW COVID-19 TESTING ACQUISITION REQUIREMENTS EXCLUSIVELY THROUGH THE DLA ECAT PROCESS AS PER REF (O). 14. [NEW] COMMUNITY OUTREACH GUIDANCE 14.A. [NEW] REF (P) ESTABLISHES POLICY AND ANNUAL REQUIREMENTS FOR NAVY COMMUNITY OUTREACH STAKEHOLDERS. DOD HPCON LEVELS, AS WELL AS GUIDELINES IMPOSED BY THE CDC AND LOCAL CIVILIAN AUTHORITIES, CURRENTLY PREVENT THE EXECUTION OF THESE REQUIREMENTS. COMMANDS ARE ENCOURAGED, HOWEVER, TO USE EXISTING VIRTUAL IT PLATFORMS TO ENGAGE WITH THE PUBLIC WHEN SOCIAL DISTANCING PROTOCOLS AND SIMILAR PUBLIC HEALTH MEASURES RESTRICT FACE-TO-FACE ENGAGEMENTS. NAVY OFFICE OF COMMUNITY OUTREACH (NAVCO) IS STANDING BY TO ASSIST COMMANDS WITH THESE EFFORTS. (POC: CDR JOHN FAGE. JOHN.E.FAGE@NAVY.MIL) 14.B. [NEW] THE RESUMPTION OF IN-PERSON COMMUNITY ENGAGEMENT REQUIREMENTS SPECIFIED IN REF (P), (PUBLIC TOURS; DISTINGUISHED VISITORS EMBARKS; PORT VISITS; FLEET WEEKS; AIR SHOWS; ETC.) WILL BE CONSIDERED BY COMMANDERS WHEN HPCON LEVELS AND CDC GUIDELINES INDICATE COVID-19 NO LONGER THREATENS THE SAFETY AND READINESS OF THE FORCE. 15. RELEASED BY VADM P. G. SAWYER, DEPUTY CHIEF OF NAVAL OPERATIONS FOR OPERATIONS, PLANS AND STRATEGY, OPNAV N3/N5.// BT #0001 NNNN UNCLASSIFIED//

On Jan. 27 the U.S. Navy relieved Frank Azzarello, commanding officer of the guided missile destroyer USS Forrest Sherman, of his post just days before his scheduled change of command. The timing and severity of the punishment call into question his superiors’ judgment. Commander Azzarello possesses an impressive operational record consistent with an admirable professional career. Under Azzarello’s command, Forrest Sherman deployed to the Near East throughout 2019 and 2020 and was a highly effective maritime interdictor. Most notably, in November 2019, the ship’s crew seized five Iranian-made 358 missiles, one of Iran’s most advanced weapons. The ship also interdicted various light weapons and smaller missiles, including the Iranian-produced Dehlavieh anti-tank missile, a weapon capable of penetrating the armor on American Abrams and Israeli Merkava battle tanks.

The U.S. Navy is looking to divest its nearly-new Mk VI patrol boats, the oldest of which are just six years old, and has already begun laying the groundwork to do so. Barring an order to change course from President Joe Biden's administration or intervention by Congress, the service plans to remove all 12 of these boats, examples of which are based in Guam, as well as in the continental United States, and forward-deployed in the Persian Gulf, from service before the end of the year.

No luck yet, unless I'm typing the wrong address.

UNCLASSIFIED// ROUTINE R 122000Z FEB 21 MID600050251809U FM CNO WASHINGTON DC TO NAVADMIN INFO CNO WASHINGTON DC BT UNCLAS NAVADMIN 039/21 MSGID/NAVADMIN/CNO WASHINGTON DC/N9/FEB// SUBJ/REVISED FY21 PROJECTED SHIP INACTIVATION SCHEDULE// REF/A/DOC/OPNAVINST 4770.5H/20140424// REF/B/DOC/OPNAVINST 5400.44A/20111013// REF/C/NAVADMIN/187/20/302033ZJUN20// NARR/REF A IS OPNAV POLICY AND GUIDANCE FOR THE INACTIVATION, RETIREMENT, AND DISPOSITION OF U.S. NAVAL VESSELS. REF B IS NAVY ORGANIZATION CHANGE MANUAL (NOCM) FOR SUBMITTING ORGANIZATIONAL CHANGE REQUESTS (OCR) TO INCLUDE SHIP DECOMMISSIONINGS OR INACTIVATIONS. REF C IS NAVADMIN ANNOUNCING FY21 SHIP INACTIVATIONS// POC/M. COOPER/CIV/OPNAV N9IS/TEL: 703-692-3534/EMAIL: max.cooper(at)navy.mil// RMKS/1. This message shall be read in its entirety to ensure all stakeholders in the ship inactivation process are aware of the revised projected retirement schedule for fiscal year 2021 (FY21), respective responsibilities and necessary follow-up actions. Ship retirement decisions reflected in paragraph 2 below align with the Presidents Budget for 2021. This plan will be adjusted if necessary based on subsequent execution year decisions made by leadership or as required by Congressional action. 2. To facilitate fleet planning efforts to conduct decommissioning continuous maintenance availability (CMAV) or inactivation availability (INAC), the revised projected schedule for inactivating U.S. battle force and non-battle force naval vessels in FY21 is promulgated as follows. Note the below listed dates reflect the projected inactivation date, which is when custody of the vessel will be transferred to the inactive ships facility and its status will be updated in the Naval Vessel Register. Decommissioning ceremony dates will be promulgated via Organizational Change Requests and inactivation SITREPS. Ship NameProjected Inactive DatePost Inactive Status USS ZEPHYR02 Mar 2021 Dismantle (PC USS SHAMAL25 Feb 2021 Dismantle (PC 13) USS TORNADO04 Mar 2021 Foreign Military Sales (PC 14) USNS SIOUX30 Sep 2021 Foreign Military Sales (T-ATF 171) USS FORT MCHENRY16 Apr 2021 OCIR (LSD 43) USS FREEDOM 30 Sep 2021OCIR (LCS 1) USS INDEPENDENCE31 Jul 2021OCIR (LCS 2) USS BONHOMME RICHARD15 APR 2021Dismantle (LHD 6) 3. Per reference (b), Fleet Commanders shall submit an Organizational Change Request for commissioned U.S. ships and per reference (a) to formally notify the Office of the Chief of Naval Operations (OPNAV) of a ships decommissioning, inactivation, or end of service. Submit revisions due to operational schedule changes per references (a) and (b). It is the responsibility of Commander, U.S. Fleet Forces Command and Commander, U.S. Pacific Fleet in coordination with their respective TYCOM to ensure the appropriate lower echelon commands are notified of any changes in the ship inactivation schedules, as well as Integrated Warfare (OPNAV N9I) and OPNAV resource sponsor. 4. Adjustments to paragraph 2 ship inactivations that cross the current fiscal year must be coordinated with OPNAV N9I due to Congressional requirements for execution year force structure changes that differ from what Congress authorized/appropriated and signed into law by the President. OPNAV shall promulgate changes to the inactivation fiscal year as required. 5. The ships commanding officer, masters, or Immediate Superior In Command, shall submit a final naval message (normally transmitted in conjunction with the decommissioning ceremony) announcing the ships official retirement date and include a brief history of the significant events in the life of the ship per reference (a). The Naval History and Heritage Command (NAVHISTHERITAGE WASHINGTON DC) and Naval Vessel Register Custodian (NVR NORFOLK VA), shall be included as INFO addees. 6. Released by VADM J. W. Kilby, N9.// BT #0001 NNNN UNCLASSIFIED//

Raytheon's Standard Missile 6, or SM-6, has sucked up most of the public's attention in recent years as it has become the most versatile surface-to-air and surface-to-surface weapon in the U.S. Navy's arsenal. Other services are now taking notice, too, and the Navy is already working on building an even more capable version. Still, the older SM-2 branch of the Standard family of missiles, also sometimes referred to collectively in its newer form as the SM-2 Medium Range (SM-2MR), remains the backbone of the Navy's area air defense capability. These missiles sit in hundreds of vertical launch cells and ships' magazines around the globe, ready to defend U.S. and allied fleets against a range of aerial threats.

Out of the sailors who have been offered a vaccine for COVID-19, about 70 percent have taken the Navy up on the shots, according to information provided to USNI News by the service. The rate, current as of late January, is better than the percentage of the national population who in December said they would get the vaccine if available, according to a December Journal of the American Medical Association study. Still, service leaders want a higher percentage of the sailors to accept the vaccine.

The sailor assigned to a Virginia-based ship who died of complications tied to the illness caused by the coronavirus this week was a 42-year-old from Hawaii. Aviation Support Equipment Technician 1st Class Marcglenn L. Orcullo, who was assigned to the amphibious assault ship Wasp, died of COVID-19 on Friday, Navy officials said in a statement. Orcullo tested positive for the virus on Jan. 17.

12 February 2021 From MC1 Mark D. Faram, Chief of Naval Personnel Public Affairs. The Navy has announced the calendar-year 2021 enlisted Meritorious Advancement Program's Season One, and with it, some new rules that commands need to be aware of. These command-level advancements, known as MAP, account for 20 percent of all enlisted advancements each calendar year. The program is a way for command triads to advance their most qualified Sailors ahead of each of the semi-annual Navy-wide Advancement (NWAE) Cycles. This year, adjustments were made to the program to ensure closer coordination between MAP and the NWAE cycles, as well as special controls for some ratings to prevent overmanning in a particular paygrade. This will allow Sailors to be advanced through MAP, while also preserving advancement opportunity for those competing in the NWAE exam cycle. The season and program changes were announced in NAVADMIN 035/21, released on Feb.11. In this cycle, Navy personnel officials will control the numbers of meritorious advancement approvals for Sailors in five rating and pay grade combinations, known as rates. These are BM3, ABF2, ABF1, ABH3 and ABH2. "The decision to control these rates was made based on a variety of factors including low NWAE advancement opportunity, and a large proportion of the community's total advancements coming from MAP," Vice Adm. John B. Nowell, Jr., the Navy's chief of personnel wrote in the message. Commands wishing to advance Sailors to any of these rates must request those approvals by routing a request through their Immediate Superior in Command (ISIC) and Type Commander (TYCOM) to their budget submitting office (BSO)/echelon II command. The template for packages can be found on the MAP homepage in MyNavy Portal. Details on how this process will work are in the NAVADMIN. Due to positive Fleet feedback, the 45-day MAP execution window will be made permanent which has proved to be ample time for commands to request quotas and execute their MAP advancements. The window was reduced last year from 60 days due to the successful automation of the MAP process in the Navy Standard Integrated Personnel System (NSIPS). Once the season starts, MAP quotas by Unit Identification Code (UIC) will be posted on MyNavy Portal. Go to https://www.mnp.navy.mil/group/advancement-and-promotion/a-enlisted-advancement-resources-and-links, then select the *Websites* tab in the blue banner. Example forms and frequently asked questions can be downloaded via MyNavy Portal at https://www.mnp.navy.mil/group/advancement-and-promotion/a-enlisted-advancement-resources-and-links, then select the *Websites* tab in the blue banner. A list of points of contact for each Budget Submitting Office (BSO) and echelon II command as well as lists of parent and subordinate UICs can also be found on this website.